Blog

Medicaid Work Requirements in 2026 for SSDI and SSI Recipients: How the Federal Community Engagement Mandate Applies to Disability Recipients, Which Exemptions Protect You, How State Implementations Diverge, and What Section 1619(b) Beneficiaries Need to Watch

Full 2026 breakdown of the OBBBA Medicaid community engagement mandate, 80-hour monthly threshold, 11 exemption categories under 42 CFR 435.930, Phase 3 enforcement states, Section 1619(b) interaction for working SSI recipients, DAC misclassification risks, and fair hearing rights.

SSDI Wage Reporting in 2026 Under 20 CFR 404.1571: How to Report Work Every Month Through My Social Security, the SSI Mobile Wage Reporting App, Form SSA-1719B, and the Toll-Free Phone Line Without Triggering an Overpayment

2026 wage reporting guide for SSDI and concurrent beneficiaries. Four reporting channels, monthly cadence under 20 CFR 404.1571-1576, Form SSA-820 for self-employment, Form SSA-821 work activity, Trial Work Period reporting, and how to avoid overpayments.

SSI Redetermination in 2026: Scheduled vs Unscheduled Reviews, the Error Prone Profile (EPP) Selection Model, Forms SSA-8202 and SSA-8203-BK, and How to Preserve Appeal Rights on Cessation or Overpayment

Full 2026 guide to SSI redetermination. Scheduled, unscheduled, and limited-issue reviews, EPPIC selection, forms SSA-8202 and SSA-8203-BK, ISM under the new food-exclusion rule, ABLE account shelter, overpayment waivers, and 10-day continuing benefits window under 20 CFR 416.1336.

ALS SSDI and Medicare No-Wait Exception 2026: How the ALS Disability Insurance Access Act Eliminated the 5-Month SSDI Waiting Period, Listing 11.10 Qualifying Diagnoses, and Same-Month Part A/B/D Enrollment

Complete 2026 guide to the ALS SSDI and Medicare no-wait provisions. Public Law 116-126 eliminated the 5-month SSDI wait. Section 226(h) eliminates the 24-month Medicare wait. Compassionate Allowance approvals in weeks, Part D enrollment for Riluzole and Radicava, and ALS/FTD qualifying variants.

SSDI and Workers' Compensation Offset in 2026: The 80% Average Current Earnings Cap, 15 Reverse Offset States, Lump-Sum Settlement Proration Language, and Attorney Fee Plus MSA Carveouts

Full 2026 breakdown of the SSDI workers' comp offset. Section 224 mechanics, 80% ACE cap, PDB offset, reverse offset states, lump-sum settlement drafting, attorney fee and MSA carveouts, ACE inflation redetermination, family maximum interactions, and how offset ends at FRA.

Disabled Adult Child (DAC) Benefits in 2026: How Childhood Disability Benefits Attach to a Parent's Retirement, Disability, or Death Record, Why the Age-22 Onset Rule Is Everything, and How Marriage Can End the Benefit

2026 guide to Disabled Adult Child (DAC) benefits also called Childhood Disability Benefits (CDB). Eligibility under 20 CFR 404.350, age-22 onset proof, 50% vs 75% PIA rates, marriage termination and protected marriages, Medicare 24-month wait, SSI-to-DAC transition, and rep payee rules.

Closed Period SSDI Disability Claims in 2026: 12-Month Durational Requirement, Medical Improvement Under 20 CFR 404.1594, Lump-Sum Backpay Math With the 5-Month Waiting Period, and Medicare Continuation

Full 2026 guide to winning a closed period SSDI award when you returned to work before the decision. Durational rules, medical improvement analysis, UWA rules, backpay math, Medicare timing, EXR for recurrence, cessation month and grace period, and how attorney fees work.

SSI Income Exclusions in 2026: The $20 General, $65 Earned, One-Half Remainder Formula, ISM Rules, VTR, PMV, Student Earned Income Exclusion, PASS Plans, and Section 1619(b) Medicaid Continuation

Complete 2026 breakdown of SSI income exclusions with real math. $20 general, $65 earned, one-half remainder, ISM (VTR and PMV), SEIE, IRWE, PASS plans, 1619(b) Medicaid thresholds by state, ABLE accounts, resource rules, and how to report income to avoid overpayments.

SSDI ALJ Hearing Preparation in 2026: What to Expect at the Office of Hearings Operations, How the 75-Day Notice Rule Works, Video vs Telephone vs In-Person Formats, Handling Medical and Vocational Experts, and What to Bring So You Do Not Sink Your Case

Complete 2026 guide to preparing for your SSDI ALJ hearing. HALLEX I-2 procedure, 75-day notice rule, 5-day evidence deadline, format choices (video/phone/in-person), medical and vocational expert cross-examination, exhibit prep, what to wear, ~55% approval rate context, and what happens after the hearing.

Vocational Expert Cross-Examination in 2026: How SSR 24-3p and the DOT vs SCOO vs OES Data Gap Give You Real Ammunition to Challenge Job Numbers, Impeach Bad Testimony, and Force the ALJ to Deal With Obsolete Occupations at Step 5

Full 2026 playbook for challenging VE testimony at SSDI hearings. SSR 24-3p on job number methodology, DOT vs OES translation problems, obsolete occupations (document preparer, addresser, nut sorter), reasoning-level RFC mismatches, off-task and absenteeism thresholds, transferable skills analysis, and post-hearing objections under HALLEX I-2-6-74.

SSDI Retroactive Benefits and the Protective Filing Date in 2026: How to Preserve Up to 12 Months of Backpay, Why the 5-Month Waiting Period Still Applies, and What Counts as a Written, Phone, Online, or In-Person Contact That Locks In Your Application Date

Full 2026 breakdown of SSDI retroactive benefits and PFD rules. 12-month backpay cap, 5-month waiting period, EOD + PFD math, phone/online/mail/in-person triggers under POMS GN 00204.010, SSA-L2 letter, the 60-day follow-up window, and how to fight when SSA gets your PFD wrong. Real backpay math with 2026 numbers.

Alleged Onset Date vs Established Onset Date in 2026: How SSR 18-1p Sets EOD in Disability Claims, Why the 5-Month Waiting Period and Medicare 24-Month Rule Tie Directly to EOD, and When Amending Onset at the ALJ Hearing Actually Makes Sense

Complete 2026 guide to AOD vs EOD in SSDI claims. SSR 18-1p rules that replaced SSR 83-20, when ALJs must call a medical expert, backpay math tied to EOD, the Medicare 24-month waiting period, date last insured protection, and when amending onset at the ALJ hearing actually pays off.

Listing 13.25 Male Genital Tract Cancer in 2026: How Penile, Testicular (Seminoma and Non-Seminoma), and Prostate Cancer Qualify for SSDI When Inoperable, Unresectable, Recurrent, or Metastasized Beyond Regional Lymph Nodes, Plus How BEP Chemo, VIP or TIP Salvage, RPLND, and Cisplatin-Refractory Status Shape the Medical Case

Full 2026 walkthrough of Listing 13.25 for SSDI and SSI. Covers penile SCC (2,240 new US cases 2026), testicular cancer (10,090 new cases, 490 deaths, near-99% cure rate for Stage I seminoma), and prostate cancer routing to 13.24. Four qualifying conditions, BEP chemo, VIP/TIP salvage, RPLND, cisplatin-refractory status, late toxicity documentation, evidence checklist, DDS timeline, and appeal path.

Trial Work Period vs Extended Period of Eligibility in 2026: The 9-Month TWP at $1,210 Threshold, the 36-Month EPE at $1,690 (Non-Blind) or $2,830 (Blind), Cessation Month, Grace Period, and Expedited Reinstatement Explained For SSDI Recipients Testing Work

Full 2026 deep dive on SSDI's two big work incentives. Trial Work Period fires at $1,210 gross/month or 80 self-employment hours (9 months in a rolling 60-month window). Extended Period of Eligibility runs 36 months after TWP ends, with 3-month grace and monthly on/off benefit switching at 2026 SGA ($1,690 non-blind, $2,830 blind). Includes cessation month mechanics, IRWE, subsidies, blind SGA rules, Medicare 93-month continuation, and Expedited Reinstatement path.

Listing 13.11 Skeletal System Cancer in 2026: How Osteosarcoma, Chondrosarcoma, Ewing Sarcoma, and Chordoma Qualify Under Prong A (Inoperable or Unresectable), Prong B (Recurrent Except Local Recurrence Controlled by Additional Surgery), and Prong C (Distant Metastases)

Full 2026 walkthrough of Listing 13.11 bone sarcoma for SSDI and SSI. Covers osteosarcoma (5-yr survival 68% localized, 27% metastatic), chondrosarcoma, Ewing sarcoma, chordoma. Three-prong rule, MAP chemo (methotrexate + doxorubicin + cisplatin), mifamurtide, denosumab, limb salvage vs amputation, evidence checklist, timeline from filing to payment, and appeal path.

Listing 13.17 Small Intestine Cancer in 2026: How Adenocarcinoma, Neuroendocrine (Carcinoid), GIST, Lymphoma, and Sarcoma of the Small Bowel Qualify for SSDI When Inoperable, Unresectable, Recurrent, or Metastatic, Plus How FOLFOX, Imatinib, Lanreotide, and Lutathera Change the CDR Timeline

Full 2026 walkthrough of SSA Listing 13.17 small bowel cancer. Adenocarcinoma (SEER Stage IV survival 12%), NET (carcinoid), GIST (imatinib-driven), lymphoma, sarcoma. Four qualifying conditions, FOLFOX, R-CHOP, imatinib, lanreotide, Lutathera peptide receptor radionuclide therapy, evidence checklist, DDS timeline, and appeal path.

Why Was My Disability Denied in 2026: The 12 Most Common Reasons SSA Denies SSDI and SSI Claims, the Real Denial Rate Numbers, and the Exact Fix for Each Denial From Reconsideration Through ALJ Hearing to Appeals Council

About 65% of initial SSDI and 70% of initial SSI claims get denied. Full 2026 walkthrough of the 12 most common denial reasons SSA gives, how to read your denial notice, and the exact next step that fixes each denial type. Includes 2026 approval rate data: recon 13%, ALJ hearing 50-55%, Appeals Council remand 12%, federal court remand 45%.

Denial Notice Anatomy 2026: How To Decode Every Section of Your SSA Notice of Disapproved Claim, Find the Real Reason SSA Said No, and Aim Your Appeal at the Exact Sequential Evaluation Step Where Your Case Stopped

Your SSA denial notice hides the real reason in code. Full 2026 walkthrough of how to read a Notice of Disapproved Claim section by section: the reason paragraph, the basis section, the DDS worksheet references, the 5 sequential evaluation steps, and how each step's language changes your appeal strategy.

Listing 13.09 Thyroid Gland Cancer in 2026: Anaplastic Auto-Qualifies (A), Metastases Beyond Regional Nodes Progressive Despite Radioactive Iodine (B), and How Lenvatinib SELECT, Sorafenib DECISION, Selpercatinib/Pralsetinib for RET, Cabozantinib and Vandetanib for MTC, Dabrafenib + Trametinib for BRAF, and RAI-Refractory Determination Shape the CDR

Listing 13.09 covers thyroid gland cancer. ACS projects 44,020 new US cases (12,150 men, 31,870 women) with 2,290 deaths in 2026. Anaplastic auto-qualifies (median OS 3-6 months). Paragraph B: DTC with metastases beyond regional nodes progressive despite RAI. Medullary variant with distant nodal/organ metastases. Molecular: BRAF V600E, RET fusions and mutations, NTRK, TERT. Modern therapy: lenvatinib SELECT, sorafenib DECISION, selpercatinib/pralsetinib for RET, cabozantinib/vandetanib for MTC, dabrafenib + trametinib for BRAF anaplastic. Post-thyroidectomy hypoparathyroidism, RLN injury, chronic RAI xerostomia.

Listing 13.27 Carcinoma of Unknown Primary (CUP) in 2026: Automatic Qualification After Appropriate Search, Adenocarcinoma vs Squamous vs Poorly Differentiated Carcinoma Workup, Molecular Tissue-of-Origin Profiling and Broad Genomic Profiling, Favorable Subsets Treated as Occult Primaries, and How Tumor-Agnostic Immunotherapy Changed the Prognosis

Listing 13.27 covers metastatic cancer where the primary site cannot be identified after appropriate workup (CUP). About 15,000-30,000 new US cases per year (2-5% of all cancer). Automatic qualification with CAL. Full 2026 walkthrough: IHC panel, CancerType ID and 92-gene classifiers, broad genomic profiling, favorable subsets (cervical SCC as H&N, axillary adeno in women as breast, peritoneal in women as ovarian, midline poorly differentiated as germ cell), and tumor-agnostic FDA approvals (pembro MSI/TMB, larotrectinib NTRK, selpercatinib RET, dabrafenib+trametinib BRAF).

Listing 13.16 Esophageal and Stomach Cancer in 2026: Inoperable or Unresectable Disease (A), Recurrent Disease (B), Metastases Beyond Regional Nodes (C), and How CheckMate 649 Nivolumab + FOLFOX, KEYNOTE-811 Pembrolizumab + Trastuzumab, T-DXd for HER2, Zolbetuximab for Claudin 18.2, FLOT, and CROSS Regimens Plus Ivor Lewis and Gastrectomy Residuals Shape the CDR

Listing 13.16 covers cancer of the esophagus and stomach. Adenocarcinoma (65% of US esophageal, dominant gastric) vs squamous cell, GE junction Siewert classification, Lauren intestinal vs diffuse, TCGA molecular subtypes (EBV, MSI-high, GS, CIN), linitis plastica, HER2 (KEYNOTE-811 pembro + trastuzumab, T-DXd second-line), claudin 18.2 zolbetuximab (SPOTLIGHT/GLOW 2024), CheckMate 649 nivo + FOLFOX, FLOT perioperative, CROSS chemoradiation, Ivor Lewis vs total gastrectomy residuals, dumping syndrome, cachexia.

Listing 13.23 Female Genital Tract Cancer (Ovarian, Uterine, Cervical, Vulvar, Vaginal, Fallopian) in 2026: Small Cell Ovarian Auto-Qualifies (A), Recurrence (B), Metastases Beyond Regional Nodes (C), and How Olaparib, Niraparib, Bevacizumab, Mirvetuximab, Dostarlimab + Chemo (RUBY), Pembro + Lenvatinib, and Tisotumab Vedotin Shape the CDR

Listing 13.23 covers ovarian, fallopian, uterine, cervical, vulvar, and vaginal cancer. Small cell ovarian auto-qualifies under Paragraph A. Ovarian 20,180 new US cases + 12,730 deaths 2026, uterine 68,510 + 13,860, cervical 12,890 + 3,860. BRCA1/2 + HRD testing for ovarian, MMR for endometrial, PD-L1 for cervical, FR-alpha for ovarian. PARP maintenance (olaparib SOLO-1, niraparib PRIMA, olaparib + bev PAOLA-1), bevacizumab GOG-0218, mirvetuximab MIRASOL for FR-alpha+ platinum-resistant, dostarlimab + chemo RUBY dMMR endometrial, pembro + lenvatinib KEYNOTE-775, pembro + chemo +/- bev KEYNOTE-826 cervical, tisotumab vedotin innovaTV 204. Radical hysterectomy vs pelvic exenteration + lymphedema.

Listing 13.21 Kidney, Adrenal, Ureter, and Bladder Cancer in 2026: Inoperable or Unresectable Disease (A), Recurrent Disease (B), Metastases Beyond Regional Nodes (C), and How Nivolumab + Cabozantinib for RCC, Enfortumab Vedotin + Pembrolizumab for Urothelial, and FGFR Inhibitors Shape the CDR

Listing 13.21 covers kidney, adrenal, ureter, and urinary bladder cancer. Paragraph A inoperable/unresectable, Paragraph B recurrent, Paragraph C metastases to or beyond regional nodes. 82,000 kidney and 83,000 bladder new cases projected 2026, clear cell RCC (75%) vs papillary/chromophobe, urothelial vs muscle-invasive vs metastatic bladder cancer, CAL for metastatic RCC and stage IV urothelial, nivolumab + cabozantinib (CheckMate 9ER), enfortumab vedotin + pembrolizumab (EV-302), belzutifan HIF-2 alpha, erdafitinib FGFR3, ileal conduit vs neobladder residuals.

Listing 13.19 Liver, Gallbladder, and Bile Duct Cancer in 2026: Any Hepatocellular Carcinoma (A), Cholangiocarcinoma and Gallbladder Cancer (B), and How Atezolizumab + Bevacizumab (IMbrave150), Durvalumab + Tremelimumab STRIDE (HIMALAYA), FGFR2 Inhibitors, and IDH1 Inhibitors Shape the CDR

Listing 13.19 covers hepatocellular carcinoma (HCC, all stages meet Paragraph A) plus cholangiocarcinoma, gallbladder cancer, and rare hepatobiliary tumors under Paragraph B. 41,630 liver/iCCA and 12,190 gallbladder cases projected 2026. HCC on CAL, atezolizumab + bevacizumab (IMbrave150) and durvalumab + tremelimumab STRIDE (HIMALAYA) first-line, gem/cis + durvalumab (TOPAZ-1) for biliary tract, pemigatinib and futibatinib for FGFR2 fusion iCCA, ivosidenib for IDH1, BCLC and Child-Pugh staging, Milan/UCSF transplant criteria, TACE/TARE Y-90 locoregional therapy.

Listing 13.20 Pancreatic Cancer in 2026: Adenocarcinoma at Any Stage (A), Islet Cell Neuroendocrine With Progression (B), Recurrent Adenocarcinoma (C), and How FOLFIRINOX, NALIRIFOX, and Olaparib for BRCA-Mutated Disease Shape the CDR

Listing 13.20 covers pancreatic cancer with near-universal SSDI qualification. Paragraph A adenocarcinoma at any stage, Paragraph B islet cell with progression, Paragraph C recurrent adenocarcinoma. CAL fast-track (14-30 days), 66,440 new cases and 51,750 deaths projected 2026, FOLFIRINOX and gem/nab-paclitaxel chemotherapy, olaparib for germline BRCA (POLO trial), NALIRIFOX from NAPOLI-3 2023, Whipple procedure residuals (exocrine insufficiency, pancreatogenic diabetes).

Listing 13.13 CNS/Brain Cancer in 2026: Grade III/IV Astrocytoma and Glioblastoma (A), Medulloblastoma or Other Primary CNS Malignancy With Progression (B), Meningeal Carcinomatosis (C), and How IDH Status, MGMT Methylation, Temozolomide, and Optune Shape Neurologic Residuals for the CDR

Listing 13.13 covers CNS malignancies. Paragraph A high-grade gliomas (GBM, anaplastic astrocytoma), Paragraph B medulloblastoma or primary brain malignancy with progression, Paragraph C leptomeningeal disease. Full walkthrough of 2021 WHO CNS5 reclassification (IDH1/IDH2, ATRX, 1p/19q, MGMT, H3 K27M), Stupp protocol (surgery + radiation + temozolomide), tumor treating fields (Optune 2011), primary CNS lymphoma high-dose methotrexate + rituximab, and how neurologic residuals drive the CDR.

Listing 13.15 Mesothelioma in 2026: Any Confirmed Malignant Mesothelioma of the Pleura, Peritoneum, Pericardium, or Tunica Vaginalis Meets the Listing Automatically Regardless of Stage or Histology

Listing 13.15 grants automatic SSDI upon confirmed mesothelioma diagnosis. Full walkthrough of pleural, peritoneal, pericardial mesothelioma, epithelioid vs sarcomatoid vs biphasic histology, asbestos exposure documentation, CheckMate 743 nivolumab + ipilimumab first-line, cisplatin + pemetrexed, tumor-treating fields (Optune Lua), cytoreductive surgery + HIPEC for peritoneal, CAL fast-track, and parallel VA/asbestos trust/litigation tracks.

Listing 13.12 Adult Skin Cancer and Melanoma in 2026: Metastases to or Beyond Regional Nodes (A), Recurrence (B), Melanoma With Nodal or Distant Spread, and How BRAF V600, Nivolumab + Ipilimumab, Nivolumab + Relatlimab, and Tebentafusp Shape the CDR

Listing 13.12 covers adult skin cancers. Any melanoma or non-melanoma skin cancer with metastases to or beyond regional lymph nodes qualifies. Full walkthrough of AJCC melanoma staging, BRAF V600 targeted therapy (dabrafenib/trametinib), checkpoint inhibitors (pembrolizumab, nivolumab, nivo + ipi, nivo + relatlimab), tebentafusp for HLA-A*02:01+ uveal melanoma, Merkel cell carcinoma, immune-related adverse events, and CAL fast-track for metastatic disease.

Listing 13.14 Lung Cancer in 2026: NSCLC Inoperable/Unresectable/Recurrent (A), Small-Cell/Oat-Cell (B), Superior Sulcus Pancoast (C), and How EGFR, ALK, KRAS G12C, and PD-L1 Shape Treatment Residuals for the CDR

Listing 13.14 grants disability under three paragraphs. NSCLC inoperable/unresectable/recurrent (A), small-cell lung carcinoma at any stage (B, automatic), superior sulcus (Pancoast) tumor with multimodal therapy (C). Full walkthrough of stage III/IV NSCLC, driver mutation testing (EGFR/ALK/ROS1/KRAS G12C), PD-L1 TPS scoring, checkpoint inhibitor irAEs, targeted therapy toxicities, radiation pneumonitis, post-lobectomy PFT decline, and CAL fast-track.

Listing 13.18 Colon and Rectum Cancer in 2026: Inoperable/Unresectable/Recurrent (A), Metastases to or Beyond Regional Nodes (B), Recurrent After TME (C), Small-Cell (D), and How KRAS/NRAS/BRAF/MSI Testing Drives Treatment

Listing 13.18 grants disability under four paragraphs for colon and rectum cancers. Full walkthrough of AJCC staging, KRAS/NRAS/BRAF testing for anti-EGFR eligibility, MSI/MMR status for pembrolizumab first-line, oxaliplatin CIPN, capecitabine hand-foot syndrome, ostomy complications, pelvic radiation late effects (proctitis, cystitis, insufficiency fractures), and CAL fast-track for metastatic disease.

Listing 13.10 Breast Cancer in 2026: Inflammatory, Locally Advanced Stage IIIB/IIIC, 10+ Axillary Nodes, Recurrence, Small-Cell, and How CDK 4/6 Inhibitors and Antibody-Drug Conjugates Fit the CDR

Listing 13.10 grants disability under five paragraphs. Full walkthrough of A (locally advanced/inflammatory), B (nodes beyond axillary), C (10+ positive axillary nodes), D (recurrence), E (small-cell). Plus HER2/receptor testing, Enhertu ADC pneumonitis, palbociclib/abemaciclib toxicity, taxane CIPN, anthracycline cardiotoxicity, radiation lymphedema, and CAL fast-track for inflammatory and metastatic disease.

Listing 13.24 Prostate Cancer in 2026: Progressive Despite Hormone Therapy (mCRPC), Visceral Metastases, Small-Cell, and How PARP Inhibitors and Lutetium-177 PSMA Fit the CDR

Listing 13.24 grants disability under three paragraphs: A (progression despite ADT/mCRPC), B (visceral metastases, NOT bone or nodes alone), C (small-cell). Full walkthrough of PSA and testosterone progression criteria, second-generation anti-androgens, taxane chemo, lutetium-177 PSMA radioligand, PARP inhibitors for BRCA/HRR-mutated disease, and long-term ADT residuals for CDR.

The Social Security Disability Award Letter in 2026: How to Read PIA, Month of Entitlement, Past-Due Benefits, Medicare Start Date, and Attorney Fee Sections Line By Line

The Notice of Award (SSA-L1039 or SSA-L2075) is the letter after SSDI approval. Full walkthrough of every number: PIA, MOE, EOD, past-due benefits, retroactive vs back pay split, 5-month waiting period, Medicare entitlement date, attorney fee withholding, WEP/GPO offsets, family maximum. What to do when the letter shows the wrong onset date or PIA.

SSDI Back Pay in 2026: Retroactive and Past-Due Calculation, When the Lump Sum Actually Arrives, How the IRS Lump-Sum Election Cuts Your Tax Bill, and the $9,200 Attorney Fee Cap

Full 2026 SSDI back pay walkthrough: EOD + 5-month waiting + 12-month retroactive cap + past-due, timing after ALJ decision by payment center, IRS section 86(e) lump-sum election that saves $500-$3,000 in taxes, the $9,200 attorney fee cap and 25 percent withholding, garnishment protection under 42 USC 407, and concurrent SSI installments.

Listing 13.06 Leukemia in 2026: How Acute Leukemia (AML, ALL, T-Cell Lymphoblastic Lymphoma) Gets 24 Months of Automatic Disability from Diagnosis, How Chronic Myelogenous Leukemia in Accelerated or Blast Phase Also Gets 24 Months, How Chronic Phase CML Meets the Listing, and How Post-Transplant Residuals Extend Disability Past the Initial Period

Listing 13.06 grants 24 months automatic disability from diagnosis or relapse of acute leukemia (AML, ALL, T-LBL, APL), or 12 months from bone marrow or stem cell transplant, whichever is later. Chronic phase CML also gets 24 months from diagnosis. Full walkthrough of Paragraph A acute leukemia rules, B1 CML accelerated/blast phase, B2a chronic phase, B2b progressive disease, TKI response criteria (MMR, CCyR, DMR), post-transplant residuals for the CDR, and pediatric 113.06.

Listing 13.05 Lymphoma in 2026: How Aggressive Non-Hodgkin Lymphoma Persisting or Recurring After Initial Therapy, Indolent Lymphoma Requiring More Than One Treatment Regimen in 12 Months, Hodgkin Lymphoma Without Complete Remission, and Mantle Cell Lymphoma Each Meet the Listing, Plus How CAR-T and Bispecific Antibody Therapy Fit the CDR

Full breakdown of SSA Listing 13.05 for lymphoma. Paragraph A1 aggressive NHL (DLBCL, PTCL, Burkitt) persisting or recurring after initial therapy. Paragraph A2 indolent NHL (follicular, marginal zone, MZL, MALT) needing more than one treatment in 12 months. Paragraph B Hodgkin lymphoma without clinically complete remission or recurrence within 12 months. Paragraph C mantle cell lymphoma. Pediatric 113.05. CAR-T and bispecific antibody residuals for the CDR.

Listing 5.12 Pancreas Transplantation in 2026: The Automatic 12 Month SSDI Approval from Transplant Date for Simultaneous Pancreas-Kidney (SPK), Pancreas After Kidney (PAK), and Pancreas Transplant Alone (PTA), How Recurrent Autoimmune Diabetes and Rejection Episodes Extend the Disability Period, and How Pre-Transplant Type 1 Diabetes with End-Organ Damage Establishes an Earlier Onset Date

Listing 5.12 grants automatic disability for 1 year from the date of a pancreas transplant. Full walkthrough of the three transplant modalities (SPK 75%, PAK 15%, PTA 10%), 5.00G residual factors, post-transplant complications (rejection 15-30% year 1, graft thrombosis 5-10%, recurrent T1DM 5-10%), pediatric 105.12, and how pre-transplant Type 1 diabetes with end-organ damage under Sections 6, 9, 11, or 2 establishes an earlier onset date.

Listing 5.11 Small Intestine Transplantation in 2026: The Automatic 12 Month SSDI Approval from Transplant Date, How TPN Weaning and Enteral Autonomy Play Into the CDR, When Rejection Episodes and PTLD and Graft-Versus-Host Disease Extend the Disability Period, and How Pre-Transplant Intestinal Failure Under 5.07 Establishes an Earlier Onset Date

Listing 5.11 grants automatic disability for 1 year from the date of a small intestine or multivisceral transplant. Full walkthrough of the rule, indications (short bowel syndrome, TPN-related liver disease, CIPO, motility disorders), post-transplant complications that extend disability beyond 12 months (ACR 30-50%, GVHD 5-10%, PTLD 15-25%), pediatric 105.11, and how pre-transplant Listing 5.07 (Intestinal Failure) establishes onset months or years earlier.

Listing 3.11 Lung Transplantation in 2026: Why Lung Transplant Recipients Get 3 Years of Automatic Disability Rather Than 1, How Chronic Lung Allograft Dysfunction and Bronchiolitis Obliterans Syndrome Extend the Window Past 36 Months, and What the CDR Actually Reviews

Listing 3.11 gives lung transplant recipients 3 years of automatic disability from surgery date, longer than any other transplant listing. Full walkthrough of the rule, indications (COPD, ILD, PAH, CF, alpha-1), post-transplant complications (primary graft dysfunction, acute rejection, CLAD/BOS/RAS, infections, PTLD), pediatric 103.11, and how the 36 month CDR actually works.

Listing 5.09 Liver Transplantation in 2026: The Automatic 12 Month SSDI Approval from Transplant Date, How the CDR Actually Works, When Rejection Episodes and HCV Recurrence and Immunosuppression Toxicity Extend the Disability Period, and How the SSA CLD Score Under 5.05G Can Establish an Earlier Onset Date

Listing 5.09 grants automatic disability for 1 year from the date of a liver transplant. Full walkthrough of the rule, indications (metabolic disease, ESLD, HCC, fulminant hepatitis), post-transplant complications that extend disability beyond 12 months, pediatric 105.09, MELD-Na allocation, and how the SSA CLD score under 5.05G can establish onset months before transplantation.

Listing 7.17 Hematological Disorders Treated by Bone Marrow or Stem Cell Transplantation in 2026: The Automatic 12 Month CAL-Level SSDI Approval from Transplant Date, GVHD Extensions, and Which Gene Therapies for Sickle Cell and Thalassemia Now Medically Equal the Listing

Listing 7.17 grants automatic 12 months of CAL-level SSDI from the transplantation date. Full walkthrough of GVHD, allogeneic vs autologous, Casgevy/Lyfgenia/Zynteglo medical equivalence per POMS DI 23022.404, pediatric 107.17, and post-12-month evaluation.

Listing 7.10 Bone Marrow Failure Disorders in 2026: Full Walkthrough of the Two-Paragraph Test for Aplastic Anemia, MDS, Myelofibrosis, and Granulocytopenia, Why 7.10A and 7.10B Are Not Interchangeable, and When to Move to 7.17 or 7.18 Instead

Full breakdown of 7.10A (three hospitalizations 48hr/30d apart in 12mo) and 7.10B (lifelong RBC transfusions every 6 weeks), plus when to move to 7.17 after transplant or 7.18 for repeated complications. Diagnostic requirements, iron overload cross-refs, and four worked cases.

Listing 7.02 Chronic Anemia in 2026: Why the Old Hematocrit 30 Percent Rule No Longer Exists, How SSA Now Evaluates Chronic Anemia Through 7.05 Hemolytic Anemias and 7.10 Bone Marrow Failure, and the Three Numbers You Actually Need to Meet a Step 3 Listing

The old 7.02 hematocrit 30 percent rule was deleted in 2015. Here is what replaced it, the three specific numbers that now meet Step 3 (hemoglobin 7.0, transfusion every 6 weeks, three hospitalizations), and four worked cases including CKD anemia refiled under 6.05.

Listing 2.11 Cochlear Implantation in 2026: The Automatic 12 Month SSDI Approval from Surgery Date, Why the HINT Word Recognition 60 Percent Threshold Is Different from the 2.10 Rule, How Bilateral and Bimodal Users Get Evaluated, and What Actually Happens at the Continuing Disability Review

Cochlear implantation grants automatic disability for 12 months from surgery. After that, HINT at 60 percent or less continues qualification. Full walkthrough of bilateral, bimodal, pediatric 102.11, and CDR mechanics with four worked cases.

Listing 8.07 Genetic Photosensitivity Disorders in 2026: Why Xeroderma Pigmentosum Meets Step 3 on the Diagnosis Alone, How Erythropoietic Protoporphyria, Cockayne Syndrome, and Bloom Syndrome Fit Under 8.07B, and What Highly Protective Environment Actually Means When SSA Reads Your File

Why XP under 8.07A meets Step 3 on the diagnosis alone with genetic testing, the two-track 8.07B criteria for extensive lesions or highly protective environment for 12 months, all 8 XP complementation groups, and worked cases for EPP, hydroa vacciniforme, and XPV.

Listing 8.08 Burns in 2026: How SSA Evaluates Burns After Surgical Management Ends, the Four Functional Criteria for Upper and Lower Extremity Loss, When to Use Listing 1.21 Instead, and Why Xeroderma Pigmentosum Under 8.07 Is the Only Skin Disorder Without Functional Testing

Post surgical-management threshold, the four functional criteria for extremity loss, chronic skin lesions and contractures under 8.00B, perineum and inguinal involvement, cross reference to Listing 1.21, and why XP under 8.07A is the only skin listing that skips functional testing.

Listing 7.18 Repeated Complications of Hematological Disorders in 2026: The Three-Complications-Per-Year Rule, the Two-Week Duration Threshold, the Three Marked-Limitation Areas, and Why This Rule Catches Pernicious Anemia, Aplastic Anemia, Myelodysplastic Syndrome, and Rare Bone Marrow Failure Syndromes That Do Not Fit Any Other Listing

The catch-all Section 7 rule: three-way frequency and duration test, marked limitation in ADL/social/concentration, coverage for pernicious anemia, aplastic anemia, MDS, PNH, autoimmune hemolytic anemia, chronic ITP, and rare marrow failure syndromes. Compares to 7.05 and 7.08 event-count structures.

Stepchild, Grandchild, and In Loco Parentis SSDI Auxiliary Benefits in 2026: The One-Year Marriage Rule, the Half-Support Dependency Test, Adopted-After-Entitlement Exceptions, and Why POMS GN 00306 Is the Section Every Family Needs to Read Before Filing

Non-biological child auxiliary benefits explained: one-year marriage rule for stepchildren, half-support dependency test for grandchildren under 20 CFR 404.358, in-loco-parentis pathway, and adopted-after-entitlement exceptions.

Mother's and Father's Benefits Under Sections 202(g) and 202(h) in 2026: The Child-in-Care Rule, Why Age 60 Does Not Apply, the 75 Percent PIA Formula, and How a Young Widow With a Disabled Child Can Draw Survivor Benefits Decades Before the Widow Age Kicks In

Widow benefits at any age: Section 202(g)/(h) mother's and father's benefits with child under 16 or disabled child in care, 75 percent PIA payment, remarriage rules, divorced-spouse variant, and family maximum interaction.

Listing 14.07 Immune Deficiency Disorders Excluding HIV in 2026: How SSA Evaluates CVID, SCID, X-Linked Agammaglobulinemia, Hyper-IgM Syndrome, Chronic Granulomatous Disease, Complement Deficiencies, the Three-Infection Rule, and the Repeated-Manifestations Path

Full 2026 guide to SSA Listing 14.07 for primary and secondary immune deficiencies excluding HIV. Paragraph A infections, Paragraph B stem cell transplant, and Paragraph C repeated manifestations with marked functional limitation.

Listing 2.09 Loss of Speech in 2026: How SSA Defines Total Loss of the Ability to Produce Audible, Intelligible, or Sustained Voice, and Why AAC Devices Do Not Disqualify You

Full 2026 guide to Listing 2.09. Audibility, intelligibility, and sustainability standards, ENT and SLP documentation, laryngectomy TEP, bilateral vocal fold paralysis, ALS, stroke, and why AAC devices do not defeat the listing.

Listing 7.08 Disorders of Thrombosis and Hemostasis in 2026: How SSA Evaluates Hemophilia A and B, Von Willebrand Disease, Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and the Three-Complication Rule

The full 2026 guide to Listing 7.08. Hemophilia A/B factor VIII/IX with and without inhibitors, VWD type 3, ITP with platelet thresholds, TTP with ADAMTS13 activity, HIT, and the three-hospitalization 48-hour rule.

Listing 2.10 Hearing Loss Not Treated With Cochlear Implantation in 2026: The 90 dB Air Conduction Rule, the 60 dB Bone Conduction Rule, the 40 Percent Word Recognition Rule, and How SSA Wants Your Audiogram Documented

The full 2026 guide to Listing 2.10. Paragraph A air 90 dB and bone 60 dB thresholds, Paragraph B word recognition 40 percent or less on NU-6 or W-22, ANSI sound booth standards, and the 2.11 cochlear implant crosswalk.

Listing 14.11 HIV Infection in 2026: The Eight Paths to SSDI Approval Including CD4 Under 50, CD4 Under 200 With Low BMI or Hemoglobin, PML, Primary CNS Lymphoma, Kaposi Sarcoma, and the Three-Hospitalization Rule

The full 2026 guide to Listing 14.11 for HIV infection. Paragraphs A-H covering Castleman disease, primary CNS lymphoma, PEL, PML, pulmonary Kaposi, CD4 thresholds, and the three-hospitalization 48-hour rule.

Listing 14.10 Sjogren's Syndrome in 2026: How SSA Evaluates Primary Sjogren's, the Anti-Ro and Anti-La Antibody Framework, the Two-Path Rule, and Why Dry Eyes and Dry Mouth Alone Are Not Enough

The full 2026 guide to Listing 14.10 for Sjogren's syndrome. Path A (two organs plus constitutional symptoms) and Path B (repeated manifestations plus marked functional limitation), with worked cases and documentation strategy.

Listing 5.02 Chronic Gastrointestinal Hemorrhage in 2026: The Three-Transfusion Rule, Why the 30-Day Spacing Matters, and How to Document Recurrent GI Bleeding for SSDI Approval

Listing 5.02 has one of the shortest rules in the Blue Book but it is very specific: three transfusions of at least 2 units each, spaced at least 30 days apart, inside a 6-month window. Full 2026 guide with worked cases (Frank, Florida, chronic small bowel angiodysplasia; Yolanda, Texas, radiation proctitis after cervical cancer).

Listing 14.06 Undifferentiated and Mixed Connective Tissue Disease in 2026: How SSA Evaluates UCTD and MCTD, the Two-Path Rule, and Why Anti-U1-RNP Positivity Is Not the Whole Story

Listing 14.06 exists for people whose disease looks like several autoimmune illnesses at once, or does not commit to any of them. Full 2026 guide to Path A (two organs plus constitutional symptoms) and Path B (repeated manifestations plus marked functional limitation), with worked cases (Priya, New York, MCTD with pulmonary hypertension; Tomas, Illinois, UCTD with repeated flares).

Listing 8.09 Chronic Skin Conditions in 2026: How SSA Now Evaluates Dermatitis, Psoriasis, Hidradenitis Suppurativa, and Bullous Disease Under One Rule

SSA consolidated Sections 8.02 through 8.06 into a single Listing 8.09 covering dermatitis, psoriasis, hidradenitis suppurativa, ichthyosis, bullous diseases, and chronic skin infections. Full 2026 guide to the two-part rule (three-month treatment persistence plus functional limitation), the four functional-limitation paths, and worked cases (Marisol, California, palmoplantar psoriasis; Devon, Georgia, Hurley Stage III HS).

Listing 14.05 Polymyositis and Dermatomyositis in 2026: The Five Paths to SSDI Approval Including Proximal Weakness, Dysphagia, Respiratory Failure, Calcinosis, and Repeated Manifestations

Listing 14.05 gives polymyositis and dermatomyositis patients five distinct paths to SSDI approval: proximal weakness with assistive device or bilateral UE loss (A), dysphagia with aspiration (B), respiratory failure (C), diffuse calcinosis (D), or repeated manifestations with two constitutional symptoms and one marked limitation (E). Worked cases: Sam (Pennsylvania, anti-HMGCR necrotizing myopathy) and Aisha (Texas, anti-Jo-1 antisynthetase with dysphagia).

Listing 3.07 Bronchiectasis in 2026: The Three-Hospitalizations-in-12-Months Rule, the 30-Day Separation and 48-Hour Duration Tests, and How Imaging Documents the Underlying Disorder

Listing 3.07 requires bronchiectasis documented by imaging plus three hospitalizations within a 12-month period, each at least 30 days apart and lasting at least 48 hours including ED time immediately before admission. Full documentation guide with 2026 SSA criteria, ED-time counting rules, worked cases (Elena, Miami, non-CF bronchiectasis with Pseudomonas; Tomas, Denver, cystic fibrosis with NTM co-infection), and how to build the paper trail that meets the listing.

Listing 14.03 Systemic Vasculitis in 2026: The Two Paths to Approval, ANCA-Associated Disease Documentation, and How Giant Cell Arteritis, GPA, EGPA, and Polyarteritis Nodosa Fit the SSA Framework

Listing 14.03 has two paths to SSDI approval for systemic vasculitis: 2+ organ involvement with constitutional symptoms, or repeated manifestations with marked functional limitation. Full 2026 guide covering GPA/Wegener's, MPA, EGPA/Churg-Strauss, giant cell arteritis, Takayasu, PAN, and Henoch-Schonlein. Worked cases: Renee (Boston, GPA with multi-organ involvement) and David (Phoenix, giant cell arteritis with visual loss).

Listing 5.07 Intestinal Failure and Short Bowel Syndrome in 2026: The 12-Month Daily Parenteral Nutrition Rule, What Counts as a Central Venous Catheter, and How To Document Dependence That Actually Meets

Listing 5.07 requires intestinal failure from SBS, chronic motility disorders, or extensive small bowel mucosal disease with dependence on daily parenteral nutrition via central venous catheter for at least 12 months. Complete documentation guide with 2026 SSA criteria, real worked examples (Kendra, Denver, Crohn's post-resection; Marcus, Nashville, chronic intestinal pseudo-obstruction), and appeal strategy.

Listing 14.04 Systemic Sclerosis and Scleroderma in 2026: The Four Paths To Approval, the Two Constitutional Symptoms Rule, and How Raynaud's Gangrene and Finger Contractures Trigger Automatic Disability

Listing 14.04 has four separate paths to SSDI approval for systemic sclerosis (scleroderma): 2+ organ involvement with constitutional symptoms, contractures and atrophy with mobility loss, Raynaud's gangrene or ulcerations, or repeated manifestations with marked functional limitation. Full 2026 criteria walkthrough with Patricia (Charleston, diffuse scleroderma with ILD and GI) and Jamal (Detroit, CREST with Raynaud's gangrene) case walkthroughs.

SSDI Trial Work Period, Extended Period of Eligibility, and Expedited Reinstatement in 2026: The Complete Work Attempt Sequence

The full 2026 SSDI work attempt sequence with real 2026 numbers: $1,210 TWP threshold, $1,690 non-blind SGA, $2,830 blind SGA, 9 TWP service months in a rolling 60-month window, 36-month EPE, Cessation Month + 2 Grace Period months, and Expedited Reinstatement with 6 months of provisional benefits. Marcus (Cleveland IT contractor) and Deborah (Phoenix retail worker with IRWEs) case walkthroughs.

SSA Overpayment 50 Percent Withholding Rule and the 30-Day Waiver Window in 2026

The 2026 SSA overpayment default is 50 percent for Title II SSDI, retirement, and survivor benefits with notices dated April 25, 2025 or later. SSI stayed at 10 percent. The 30-day waiver window freezes collection. Full SSA-632 waiver, SSA-561 reconsideration, and SSA-634 rate change playbook. Marjorie (retirement waiver win in Charleston SC) and Trevor (Detroit SSDI work overpayment recount win) case walkthroughs.

Listing 3.14 Respiratory Failure in 2026: The 48-Hour Twice-in-12-Months Ventilation Rule

Blue Book rule for respiratory failure due to any chronic respiratory disorder except CF. Requires invasive mechanical ventilation, noninvasive BiPAP, or a combination, for a continuous period of at least 48 hours per episode (72 if postoperative), twice within a 12-month period at least 30 days apart. CPAP does not count. Why the BiPAP vs CPAP distinction matters, how to reconstruct continuous ventilation from RT flow sheets, San Antonio TX COPD win + Buffalo NY OHS reconsideration win.

Listing 5.08 Weight Loss Due to Any Digestive Disorder in 2026: The BMI 17.5 Twice-in-12-Months Rule

Blue Book rule for weight loss from any digestive disorder. BMI under 17.50 on at least two evaluations at least 60 days apart within a 12-month period, despite adherence to prescribed medical treatment. Crohn's, chronic pancreatitis, gastroparesis, celiac, short bowel, achalasia all qualify. Eating disorders go to 12.13. Why the 17.50 threshold, how to build the adherence file, Miami FL Crohn's short bowel win + Denver CO diabetic gastroparesis reconsideration win.

Listing 3.09 Chronic Pulmonary Hypertension in 2026: The 40 mm Hg Right Heart Cath Rule

Blue Book rule for chronic pulmonary hypertension due to any cause. One test: mean pulmonary artery pressure of 40 mm Hg or greater on right heart catheterization while medically stable per 3.00L and 3.00E2a. SSA will not pay for a cath. Covers WHO Groups 1 through 5, why the 40 threshold differs from the 2022 ESC/ERS hemodynamic definition of 20, and how sotatercept and triple therapy affect the listing. Charlotte NC idiopathic PAH win + Detroit MI Group 2 HFpEF-PH RFC win.

Listing 11.11 Post-Polio Syndrome in 2026: Motor Disorganization, Speech, Bulbar Dysfunction, and Marked Physical Plus Mental Domain

Blue Book rule for post-polio syndrome. Four paths: (A) motor disorganization in two extremities with extreme limitation and bilateral assistive devices per 11.00D1/D2, (B) unintelligible speech per 11.00E3, (C) bulbar and neuromuscular dysfunction requiring invasive mechanical ventilation or PEG/parenteral nutrition per 11.00F, or (D) marked physical limitation plus marked mental limitation in one of four domains per 11.00G. Around 440,000 US polio survivors alive today. Cleveland OH Path A meet + Sacramento CA Path D hearing win.

Listing 4.11 Chronic Venous Insufficiency in 2026: Brawny Edema, Stasis Dermatitis, and 3-Month Ulcer Rule

Blue Book rule for chronic venous insufficiency. Two paths: (A) brawny non-pitting edema covering two-thirds of ankle-to-knee or distal one-third of ankle-to-hip per 4.00G3, or (B) varicosities plus stasis dermatitis plus recurrent or persistent ulcer that has not healed after 3 months of prescribed treatment. Requires deep venous system incompetency or obstruction on duplex ultrasound. Tampa FL post-thrombotic ulcer case and Cleveland OH bilateral CVI measurement case.

Listing 11.22 Motor Neuron Disorders Other Than ALS in 2026: Primary Lateral Sclerosis, Progressive Muscular Atrophy, Kennedy Disease

Blue Book rule for motor neuron disorders that are not ALS. Three paths: (A) extreme limitation in two extremities per 11.00D2 with two canes/two crutches/walker, (B) invasive mechanical ventilation or PEG/parenteral nutrition per 11.00F, or (C) marked physical limitation plus marked limitation in one of four mental functioning domains per 11.00G. Covers PLS, PMA, PBP, adult SMA, and Kennedy disease. Phoenix AZ PLS Path A case and Milwaukee WI Kennedy disease Path C case.

Listing 4.09 Heart Transplant in 2026: One Year Automatic Disability, Then Residual Impairment Under 4.02

Blue Book rule for heart transplant. One year automatic disability from the surgical date. Then evaluation of residual impairment under 4.02 chronic heart failure, 4.04 ischemic heart disease, 4.05 arrhythmias, or non-cardiac listings for immunosuppression side effects. EOD often earlier than surgery date. Boston MA post-transplant CDR case and Houston TX late-filing case.

Listing 4.10 Aneurysm of Aorta or Major Branches in 2026: Dissection Not Controlled by Prescribed Treatment

Blue Book rule for aortic aneurysm. Requires imaging plus dissection not controlled by prescribed treatment under Section 4.00H6: persistent pain from progression, size increase, or branch vessel compression causing organ malperfusion. Atherosclerosis, cystic medial necrosis, Marfan, and trauma etiologies. Chicago IL Type B malperfusion case and Atlanta GA Marfan post-repair case.

Listing 4.06 Symptomatic Congenital Heart Disease in 2026: How Cyanosis With Hematocrit 55 or PO2 60, Eisenmenger Physiology at 5 METs, or Pulmonary Systolic Pressure 70 Percent of Systemic Meets the Rule

Blue Book rule for adults with congenital heart defects. Path A cyanosis at rest with hematocrit 55+ or SpO2 under 90 percent. Path B Eisenmenger physiology with PO2 at or below 60 Torr at 5 METs or less. Path C pulmonary artery systolic pressure at 70 percent of systemic or higher. Boston MA Tetralogy of Fallot late cyanosis and Houston TX unrepaired VSD with Eisenmenger worked cases.

Listing 3.04 Cystic Fibrosis in 2026: How FEV1 at or Below Table VII-A or VII-B, Three Hospitalizations, Chest-Tube Pneumothorax, Vascular Embolization Hemoptysis, or Two of Four Chronic Complications Meets the Rule

Blue Book rule for cystic fibrosis. Seven paths A through G. Path A FEV1 by height and age. Path B three inpatient hospitalizations in 12 months. Path C spontaneous pneumothorax with chest tube. Path D 48-hour ventilation. Path E hemorrhage requiring embolization. Path F SpO2 by altitude tier. Path G two-of-four chronic complications. Denver CO combined Path A + G and Miami FL Path B worked cases.

Listing 4.05 Recurrent Arrhythmias in 2026: How Uncontrolled Cardiac Syncope or Near Syncope Documented by Holter ECG Coincident With the Event Meets the Rule Despite a Pacemaker, ICD, or Antiarrhythmic Drug

Blue Book rule for recurrent arrhythmias with uncontrolled syncope despite prescribed treatment. Coincident Holter or event monitor tracing requirement. Reversible cause exclusions (electrolytes, digitalis, antiarrhythmic drug toxicity). Which rhythms qualify: VT, SVT, AFib with tachy brady, complete heart block after pacemaker, long QT, Brugada, WPW post ablation. Springfield MA SVT and Tampa FL post MI VT with ICD worked cases.

Listing 3.03 Asthma in 2026: How FEV1 at or Below Table VI-A or VI-B, or Three Hospitalizations of 48 Hours Each at Least 30 Days Apart Within 12 Months Despite Biologic Therapy Meets the Rule

Blue Book rule for severe asthma. Two paths: Path A post bronchodilator FEV1 at or below Table VI-A threshold by height, or Path B three hospitalizations of at least 48 hours each, 30 days apart, within 12 months. Biologic therapy documentation for Xolair, Nucala, Cinqair, Fasenra, Dupixent, Tezspire. Observation vs inpatient status trap. Cambridge MA eosinophilic asthma and Jacksonville FL steroid dependent worked cases.

On the Record Fully Favorable Decision in 2026: How HALLEX I-2-1-55 Lets You Skip the ALJ Hearing, the OTR Brief Structure That Actually Works, and the Evidence Mix That Convinces an ALJ to Decide on Paper

How OTR requests under HALLEX I-2-1-55 let claimants win SSDI without a hearing. Seven section brief structure. Five OTR case signatures: listing meet, equivalence with source opinion, Grid rule, CE opinion adopted, DAC eligibility. Senior Attorney Adjudicator path under HALLEX I-2-1-56. Timing, attorney fees, common mistakes. Springfield MA Listing 1.15 meet and Tampa FL Grid rule 201.14 worked cases.

SSDI Bench Decisions in 2026: How HALLEX I-2-8-40 Lets an ALJ Announce a Fully Favorable Decision at the Hearing, the Case Profile That Triggers One, and the Written Decision That Follows Within Days

Bench decisions under HALLEX I-2-8-40. Six case patterns that produce bench favorables: listing meet confirmed at hearing, equivalence with ME testimony, Grid rule direction, step 5 no jobs, high credibility long duration testimony, combined severe impairments. OTR vs bench decision matrix. Written decision timing. Boston MA Listing 12.04 and Tampa FL Grid rule 201.06 worked cases.

Listing 1.21 in 2026: Soft Tissue Injury Under Continuing Surgical Management SSDI for Severe Burns, Crush Injuries, Degloving, and Necrotizing Soft Tissue Infections With Paragraph A Continuing Surgical Management and Paragraph B Major Function Not Restored Within 12 Months

Blue Book rule for soft tissue injuries under active operative treatment. Severe burns with Integra, StrataGraft, Epicel cultured autografts. Fournier gangrene, necrotizing fasciitis type I II III, gas gangrene. Crush injuries and compartment syndrome. Radiation-induced necrosis with HBO. Serial debridement, wound VAC, free tissue transfer. Springfield MA 55 percent TBSA and Tampa FL Fournier gangrene worked cases.

Listing 11.20 in 2026: Coma or Persistent Vegetative State SSDI After Anoxic Brain Injury, TBI, Stroke, and Metabolic Encephalopathy With the One Month Rule and MCS Distinction Under GCS, CRS-R, and 2018 DoC Guidelines

Blue Book rule for coma or persistent vegetative state (unresponsive wakefulness syndrome) lasting one month. Aspen Workgroup MCS definition. CRS-R gold standard, GCS, FOUR score. Post-cardiac arrest anoxic HIE with SSEP N20, NSE, cortical laminar necrosis. Locked-in syndrome distinction. Compassionate Allowance flags for Severe TBI and Anoxic Brain Damage. Lowell MA post-arrest VS and Gainesville FL post-TBI MCS worked cases.

Listing 11.05 in 2026: Benign Brain Tumors SSDI for Meningioma, Vestibular Schwannoma, Pituitary Adenoma, Craniopharyngioma Under Paragraph A Motor Disorganization and Paragraph B Marked Physical Plus Marked Mental

Blue Book rule for non-malignant brain tumors. WHO Grade I meningioma, vestibular schwannoma (acoustic neuroma), pituitary adenoma, craniopharyngioma, hemangioblastoma, colloid cyst. Same-side arm plus leg counts as two extremities. Vestibular loss meets balance endpoint. Cranial radiation cognitive decline. NF2, VHL, BRAF V600E targeted treatment. Cambridge MA meningioma and Miami FL craniopharyngioma worked cases.

Listing 1.23 in 2026: Non-Healing or Complex Fracture of the Upper Extremity SSDI for Humerus, Radius, and Ulna Non-Union and Malunion Under Continuing Surgical Management

Blue Book rule for shaft non-union of humerus, radius, or ulna under continuing surgical management. 1.00O1 continuing surgical management, 1.00E4 fine and gross movement loss, 1.00C6d(ii)(B) one-handed assistive device documented medical need. Exchange nailing, Masquelet, Ilizarov, BMP-2 augmentation, free vascularized fibula. DASH, Jamar grip, PRWE. Worcester MA humeral non-union and Jacksonville FL both-bone forearm worked cases.

Listing 11.13 in 2026: Muscular Dystrophy SSDI Claims Under Paragraph A Disorganization of Motor Function in Two Extremities With Extreme Limitation and Paragraph B Marked Physical Limitation Plus Marked Mental Limitation

Blue Book rule for progressive muscle disease. Duchenne, Becker, myotonic type 1 and 2, FSHD, limb-girdle, oculopharyngeal, Emery-Dreifuss. CK, genetic testing (dystrophin, DMPK, D4Z4, PABPN1), muscle biopsy, EMG, PFTs and echocardiogram. Paragraph A extreme motor limitation, Paragraph B marked physical plus marked mental. Deflazacort, mexiletine, BiPAP, ACE inhibitors. Cambridge MA and Miami FL worked cases.

Listing 11.17 in 2026: Neurodegenerative Disorders of the Central Nervous System SSDI for Huntington Disease, Spinocerebellar Ataxias, FXTAS, Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy

Catch-all Blue Book rule for progressive CNS neurodegeneration. Compassionate Allowance processing for HD adult onset, PSP, CBD, MSA, and select SCA subtypes. Hummingbird sign, hot cross bun sign, caudate atrophy, cerebellar atrophy, middle cerebellar peduncle changes. Genetic testing HTT FMR1 SCA panels. UHDRS, SARA, PSP rating. Boston MA Huntington and Fort Lauderdale FL PSP worked cases.

Listing 1.19 in 2026: Pathologic Fractures Due to Any Cause SSDI Claims Under Paragraph A Three Pathologic Fractures on Three Separate Occasions Within a 12-Month Period and Paragraph B Inability to Use an Upper Extremity or Documented Medical Need for a Walker, Bilateral Canes, Bilateral Crutches, or a Wheeled and Seated Mobility Device

Blue Book rule for disease-driven fractures. Paragraph A three pathologic fractures on three separate occasions within a rolling 12-month window. Paragraph B upper extremity fine and gross movement loss under 1.00E4 or bilateral assistive device under 1.00C6a and 1.00C6d. Multiple myeloma, metastatic bone disease, severe osteoporosis, Paget disease, chronic corticosteroid osteopenia, osteogenesis imperfecta, renal osteodystrophy. Cambridge MA and Fort Lauderdale FL worked cases.

Listing 11.07 in 2026: Cerebral Palsy Adult SSDI Claims Under Paragraph A Disorganization of Motor Function in Two Extremities With Extreme Limitation, Paragraph B Marked Physical Plus Marked Mental Limitation, and Paragraph C Significant Interference in Communication From Speech, Hearing, or Visual Deficit

Adult claims under the Blue Book cerebral palsy listing. Spastic diplegia, hemiplegia, quadriplegia, dyskinetic, and ataxic types. GMFCS I to V and MACS I to V mapping. Paragraph A extreme limitation in stand, balance, or upper extremity use. Paragraph B marked physical plus marked mental. Paragraph C communication deficit. Post-impairment syndrome, DAC and SSI pathways. Boston MA and Tampa FL worked cases.

Listing 1.17 in 2026: Reconstructive Surgery or Surgical Arthrodesis of a Major Weight-Bearing Joint SSDI Claims Under Paragraph A History of Reconstructive Surgery or Arthrodesis, Paragraph B Impairment-Related Physical Limitation Lasting or Expected to Last at Least 12 Months, and Paragraph C Documented Medical Need for a Walker, Bilateral Canes, or Bilateral Crutches

Hip THA, knee TKA, and ankle TAA or tibiotalar arthrodesis claims. Paragraph A history of the qualifying surgery under 1.00S. Paragraph B 12-month physical limitation. Paragraph C documented medical need for walker, bilateral canes, bilateral crutches, or both-hands wheelchair under 1.00C6a and 1.00C6d. Periprosthetic joint infection two-stage revision, aseptic loosening, PAO HTO DFO osteotomies, Vancouver and Rorabeck fractures, MUA stiffness. Springfield MA infected TKA and Miami FL bilateral ankle fusion worked cases.

Listing 11.12 in 2026: Myasthenia Gravis SSDI Claims Under Paragraph A Bulbar and Neuromuscular Weakness Despite Therapy, Paragraph B Myasthenic Crisis Requiring Intubation, and Paragraph C Marked Physical Plus Marked Mental Limitation

Autoimmune neuromuscular junction disorder. Paragraph A significant motor disorganization despite adherence for 3 months. Paragraph B myasthenic crisis with intubation or BiPAP 3 times in 12 months. Paragraph C marked physical plus marked mental limitation under 11.00G. AChR MuSK LRP4 antibody testing, RNS 10 percent decrement, single fiber EMG jitter, thymectomy MGTX evidence. Eculizumab, ravulizumab, zilucoplan, efgartigimod, rozanolixizumab. Cambridge MA and Orlando FL worked cases.

Listing 1.22 in 2026: Non-Healing or Complex Fracture of the Femur, Tibia, Pelvis, or Talocrural Bones SSDI Claims Under Paragraph A Solid Union Not Evident on Imaging and Paragraph B 12-Month Limitation With Bilateral Assistive Device

High-energy trauma non-unions in the major weight-bearing bones. Paragraph A persistent fracture line, atrophic and hypertrophic non-union, pseudarthrosis, 1.00C3 imaging. Paragraph B walker or bilateral canes or bilateral crutches under 1.00C6a and 1.00C6d(i). Exchange nailing, BMP-2, Ilizarov, Masquelet technique, infected non-union. Pelvic ring non-unions on CT. Worcester MA pilon and Jacksonville FL Tile C pelvic ring worked cases.

Listing 11.10 in 2026: ALS SSDI Claims Under Compassionate Allowance Fast Track With Bulbar and Spinal Onset Pathways, Gold Coast and El Escorial Criteria, ALSFRS-R Tracking, and the FDA 2026 Treatment Picture

ALS as Compassionate Allowance with 5-month SSDI and 24-month Medicare waiting periods waived by Public Law 116-126. Gold Coast 2020 versus revised El Escorial. EMG showing active and chronic denervation across body regions. Bulbar versus spinal onset. FDA 2026 picture: riluzole, edaravone IV and oral, tofersen for SOD1, Relyvrio withdrawn April 2024. ALS-FTD spectrum and ECAS. Boston MA bulbar onset and Miami FL SOD1 D90A spinal onset worked cases.

Listing 1.16 in 2026: Lumbar Spinal Stenosis SSDI Claims Under Paragraph A Pseudoclaudication, Paragraph B Sensory or Reflex Findings, Paragraph C Imaging of Cauda Equina Compromise, and Paragraph D 12-Month Limitation With Bilateral Assistive Devices

The 2021 musculoskeletal revision rewrote how SSA evaluates stenosis. Paragraph A nonradicular pseudoclaudication. Paragraph B cauda equina compromise on MRI (Schizas C or D, CSF effacement, nerve root crowding). Paragraph C 12-month duration plus bilateral assistive device under 1.00C6a. Failed back surgery, SCS, ESI failure record, and Grid Rule 201.06 fallback. Worked Worcester MA multi-level stenosis and Jacksonville FL failed fusion cases.

Listing 11.08 in 2026: Spinal Cord Disorders SSDI Claims Under Paragraph A Complete Loss of Function for Three Consecutive Months, Paragraph B Two-Extremity Motor Disorganization, or Paragraph C Marked Physical Plus Marked Mental Limitation

ASIA Impairment Scale A through D, the three-month rule that controls all three paragraphs, the 90-day repeat exam as the dispositive anchor, bowel and bladder dysfunction, autonomic dysreflexia for above-T6 injuries, intrathecal baclofen, Onward ARC-IM stimulation. Worked Boston C6 tetraplegia and Tampa T11 incomplete paraplegia cases. Compassionate Allowance overlay for severe cervical complete injuries.

TERI Cases in 2026: How the Terminal Illness Flag Under POMS DI 23020.045 Pulls an SSDI Claim Out of the Regular Queue, the 30 Day DDS Target, the SSA-3033 Path, and the Auto-Trigger Condition List

The TERI processing flag under POMS DI 23020.045 and field office POMS DI 11005.601. Auto-trigger conditions (ALS, Stage IV cancers, pancreatic cancer, hospice, transplant candidates). SSA-3033 path for non-auto cases. 30 day DDS target, CE skip rules, payment center pull-forward. CAL plus TERI double flag. Worked Worcester MA pancreatic and Tampa FL Stage IIIB lung cancer cases.

SSDI for Homeless Claimants in 2026: How POMS DI 11005.604 Sets Expedited Processing, the SOAR Program Approval Rate Jump From 13 to 65 Percent, Mailing Address Workarounds, and the Third-Party Representative Path

Homelessness does not disqualify SSDI. POMS DI 11005.604 expedited processing. SOAR program raises initial approval rates from 13 to 65 percent. Six accepted mailing address types. Direct Express debit card path for no-bank claimants. Representative payee selection. ER, FQHC, and street medicine records as acceptable medical evidence. Worked Boston schizophrenia and Houston PTSD plus DDD concurrent cases.

Listing 11.09 in 2026: Multiple Sclerosis SSDI Claims Under Paragraph A Disorganization of Motor Function in Two Extremities With Extreme Limitation, or Paragraph B Marked Physical Plus Marked Mental Limitation in One of Four Functional Areas

Paragraph A two-extremity motor disorganization with extreme limitation. Paragraph B marked physical plus marked mental in one of four areas. McDonald 2024 MRI criteria. EDSS 6.5 threshold. BICAMS cognitive battery (SDMT, CVLT-II, BVMT-R). Anti-CD20 DMTs (Ocrevus, Kesimpta, Briumvi) and S1P modulators. T25-FW and 9HPT functional tests. Worked Worcester MA RRMS-to-SPMS and Tampa FL PPMS cases.

Listing 1.18 in 2026: Abnormality of a Major Joint SSDI Claims for Hip, Knee, Shoulder, Ankle, and Wrist Under Paragraph A Chronic Joint Pain or Stiffness, Paragraph B Abnormal Motion or Instability, Paragraph C Anatomical Abnormality, and Paragraph D 12-Month Functional Limitation Plus Walker or Bilateral Cane Documentation

Four-paragraph rule for major joint disorders. 1.00I major joint definitions (shoulder, elbow, wrist-hand, hip, knee, ankle-foot). 1.00C6 assistive device documentation and 1.00C6a documented medical need. 1.00C7c four-month proximity rule. Kellgren-Lawrence imaging, post-arthroplasty PJI and dislocation complications, biologic DMARDs for inflammatory arthritis. Worked Worcester MA bilateral knee OA and Tampa FL failed THA cases.

Listing 12.07 in 2026: Somatic Symptom, Illness Anxiety, and Conversion Disorder SSDI Claims Under Paragraph A Three Pathways and Paragraph B Marked or Extreme Limitation in Two of Four Mental Functioning Areas (No Paragraph C)

The three Paragraph A pathways: altered motor or sensory function, distressing somatic symptoms, or preoccupation with serious illness. Why 12.07 has no Paragraph C and the Step 5 RFC pathway. PHQ-15, SSS-8, Whiteley Index, MMPI-2-RF scoring. Video EEG for pseudoseizures. Hoover sign for conversion. Worked Worcester MA conversion and Tampa FL illness anxiety cases.

Listing 12.11 in 2026: Adult Neurodevelopmental Disorder SSDI Claims for ADHD, Specific Learning Disorder, Borderline Intellectual Functioning, and Tourette Syndrome Under Paragraph A and Paragraph B Marked or Extreme Limitation (No Paragraph C)

Adult ADHD, specific learning disorder, borderline intellectual functioning, and Tourette syndrome. ASRS-v1.1, CAARS, WAIS-IV, WIAT-4, BRIEF-A, YGTSS scoring. Childhood evidence for developmental onset. Stimulants, alpha-2 agonists, VMAT2 inhibitors (Ingrezza for Tourette 2023), CBIT. Why 12.11 has no Paragraph C and the Step 5 RFC pathway. Worked Boston MA adult ADHD and Jacksonville FL Tourette cases.

Listing 12.02 in 2026: Neurocognitive Disorder SSDI Claims for Alzheimer, Vascular Dementia, Frontotemporal, Lewy Body, TBI, and Parkinson Cognitive Disorder Under Paragraph A Six Cognitive Domains, Paragraph B Marked or Extreme in Two of Four Areas, and Paragraph C Marginal Adjustment

Paragraph A six cognitive domains (complex attention, executive function, learning/memory, language, perceptual-motor, social cognition). MMSE under 24, MoCA under 26, WMS-IV, WAIS-IV, Trail Making, Boston Naming, Rey Complex Figure. Imaging: amyloid PET, FDG-PET, MRI atrophy patterns, DaTscan. Donepezil, memantine, lecanemab, donanemab evidence. Worked Worcester MA early-onset Alzheimer and Orlando FL post-TBI cases.

Listing 12.08 in 2026: Personality and Impulse-Control Disorder SSDI Claims for Borderline, Antisocial, Paranoid, Schizoid, Schizotypal, Avoidant, Dependent, and OCPD Plus Intermittent Explosive Disorder Under Paragraph A Nine Pervasive Patterns and Paragraph B Marked or Extreme in Two of Four Areas (No Paragraph C)

Nine pervasive Paragraph A patterns covering every DSM-5-TR personality disorder plus IED. SCID-5-PD, PID-5, MMPI-2-RF, MCMI-IV, PAI, ZAN-BPD scoring. Why there's no Paragraph C and what that means. DBT, MBT, schema therapy, TFP. Section 12 MA / Baker Act FL involuntary commitments. Worked Boston MA borderline and Miami FL IED cases including Step 5 fallback strategy.

Listing 12.06 in 2026: How Social Security Decides Anxiety and Obsessive-Compulsive Disorder SSDI Claims Under Paragraph A Six Anxiety Symptoms, Panic, Agoraphobia and OCD Criteria, Paragraph B Marked or Extreme Limitation in Two of Four Mental Functioning Areas, and the Paragraph C Two-Year Serious and Persistent Marginal Adjustment Path

Paragraph A1 anxiety symptoms (need 3 of 6), A2 panic plus persistent concern or agoraphobia, A3 OCD intrusive thoughts and compulsions. Y-BOCS 24+ severe, GAD-7 15+ severe, Panic Disorder Severity Scale, Liebowitz Social Anxiety. Paragraph B four areas, Paragraph C marginal adjustment. Plus medications, ERP, Section 12 MA, Baker Act FL, and worked Erin Worcester and David Orlando cases.

Listing 12.03 in 2026: How Social Security Decides Schizophrenia Spectrum and Other Psychotic Disorder SSDI Claims Under Paragraph A Delusions, Hallucinations, Disorganized Thinking or Behavior, Paragraph B Marked or Extreme Limitation in Two of Four Mental Functioning Areas, and the Paragraph C Two-Year Serious and Persistent Marginal Adjustment Path

Paragraph A medical criteria for schizophrenia, schizoaffective, delusional, schizophreniform and brief psychotic disorder. PANSS, BPRS, BACS, MATRICS, SANS, BNSS scoring. First and second generation antipsychotics, long-acting injectables, clozapine REMS for treatment-resistant. ACT teams, supportive housing, payee as 12.00D highly structured settings. Worked Marcus Springfield and Tiffany Miami cases including DAA materiality.

Listing 12.04 in 2026: How Social Security Decides Depressive, Bipolar and Related Disorder SSDI Claims Under Paragraph A Medical Criteria, Paragraph B Marked or Extreme Limitation in Two of Four Areas of Mental Functioning, and the Paragraph C Two-Year Marginal Adjustment Path That Wins When Paragraph B Falls Just Short

Paragraph A medical criteria for major depressive disorder and bipolar I and II, the four areas of mental functioning in Paragraph B with the marked vs extreme severity scale, the two-year serious and persistent path in Paragraph C with the marginal adjustment test, plus the treatment record and worked Massachusetts and Florida cases.

Listing 1.15 in 2026: How Social Security Decides Skeletal Spine SSDI Claims for Cervical and Lumbar Nerve Root Compromise Under Paragraph A Radicular Symptoms, Paragraph B Neurological Signs, Paragraph C Imaging Confirmation, and Paragraph D 12-Month Functional Limitation With Walker, Bilateral Cane, Crutch, or Wheelchair Documentation

The four-paragraph spine listing for nerve root compromise from herniated disc, spinal stenosis, spondylolisthesis, degenerative disc disease, and facet arthritis. Paragraph A radicular symptoms, Paragraph B muscle weakness plus nerve root irritation plus sensory or reflex findings, Paragraph C imaging consistent with compromise, Paragraph D assistive device requirement. Plus the 4-month close proximity rule.

Listing 11.14 in 2026: How Social Security Decides Peripheral Neuropathy SSDI Claims Under Paragraph A Two-Extremity Motor Disorganization, Paragraph B Marked Physical Plus Marked Mental Limitation, and the Nerve Conduction Evidence That Decides Diabetic, Chemo Induced, and Inflammatory Neuropathy Files

The 11.00D motor disorganization standard, the 11.00G marked physical plus marked mental path, NCS and EMG documentation, diabetic neuropathy, chemo induced peripheral neuropathy, CIDP, GBS, CMT, alcoholic, vasculitic, plus RFC math and worked examples in Massachusetts and Texas.

Listing 12.13 in 2026: How Social Security Decides Eating Disorder SSDI Claims Under Paragraph A Persistent Alteration in Eating Behavior and Paragraph B Marked or Extreme Limitation in Mental Functioning, Plus the Medical Complications Paths Most Files Miss

Anorexia nervosa, bulimia, binge eating disorder, ARFID, OSFED. Paragraph A persistent alteration plus impairs physical or psychological health. Paragraph B marked in two or extreme in one of four mental areas. Parallel listing 5.08 weight loss and 4.05 arrhythmia paths. Massachusetts and Florida worked examples.

Listing 11.06 in 2026: How Social Security Decides Parkinsonian Syndrome and Parkinson Disease Claims Under Paragraph A Two-Extremity Motor Disorganization, Paragraph B Marked Physical Plus Marked Mental Limitation, and the 3 Month Adherence Rule That Drives the File

The 11.00C 3 month rule on prescribed treatment, Paragraph A two-extremity motor disorganization with 11.00D1 and D2 definitions, Paragraph B marked physical plus marked mental with 11.00G, MDS-UPDRS scoring, Hoehn and Yahr staging, Compassionate Allowance pathways for MSA, PSP, CBD, and ALS-Parkinsonism Dementia Complex, plus worked examples for Texas and California.

Listing 11.18 in 2026: How Social Security Decides Traumatic Brain Injury SSDI Claims Under Paragraph A Two-Extremity Motor Disorganization, Paragraph B Marked Physical Plus Marked Mental Limitation, and the 3 Month Rule That Forces SSA to Defer Adjudication After the Injury

The 11.00Q 3 month deferral rule, Paragraph A two-extremity motor disorganization, Paragraph B marked physical plus marked mental limitation, closed vs penetrating vs blast TBI evidence, GCS, FIM, and Berg Balance scoring, the Wounded Warrior expedited pathway, 100 percent VA P&T status, the no-offset rule between VA and SSDI, plus worked examples for Pennsylvania construction and Florida veteran blast injury.

CRPS and RSDS Under SSR 03-2p in 2026: How Social Security Decides Complex Regional Pain Syndrome Claims Without a Listing, the Six Clinical Signs That Win Cases, and the RFC Path Most Claimants Need

No Blue Book listing for CRPS. SSR 03-2p directs equivalence to listings 1.15, 1.16, 11.14 or RFC at step 5. The six clinical signs (swelling, autonomic instability, hair or nail growth changes, osteoporosis, involuntary movements, allodynia), the less than sedentary RFC limits, and worked examples for California and Texas.

POTS Syndrome SSDI in 2026: How Social Security Decides Postural Orthostatic Tachycardia Claims Without a Listing, the Tilt Table Test That Anchors Every File, and the Equivalence Path to Listings 4.05 and 11.14

Tilt table criteria (30 bpm jump in adults, 40 bpm in adolescents), the four POTS subtypes, equivalence to Listing 4.05 recurrent arrhythmias or Listing 11.14 peripheral neuropathy, the long COVID overlap, the comorbid conditions (EDS, MCAS, ME/CFS), and the RFC limits that win step 5 cases.

Listing 7.05 in 2026: How Social Security Decides Sickle Cell, Thalassemia, and Hemolytic Anemia Claims Under Paragraph A 6 Pain Crises, Paragraph B 3 Hospitalizations, Paragraph C Hemoglobin Under 7.0, and Paragraph D Beta Thalassemia Major

The four paths under 7.05 covering hemolytic anemias including sickle cell and thalassemia, the 6 vaso-occlusive crises with parenteral narcotic rule, the 3 hospitalizations of 48 hours rule, the hemoglobin 7.0 g/dL threshold under paragraph C, beta thalassemia major transfusion dependence under paragraph D, plus the residual 7.18 path for repeated complications.

Listing 12.10 in 2026: How Social Security Decides Adult Autism Spectrum Disorder Claims Under Paragraph A Medical Criteria Plus Paragraph B Marked Limitations in Two Areas or One Extreme, and Why the B Criteria Decide Almost Every Case

The two paragraphs of 12.10 covering adult autism spectrum disorder, the medical criteria under paragraph A, the four functional areas under paragraph B, what marked and extreme actually mean, the ADOS-2 and neuropsych testing that wins cases, adult-diagnosed autism, and the residual RFC path with non-exertional limitations.

Listing 11.04 in 2026: How Social Security Decides Stroke and Vascular Insult Claims Under Paragraph A Aphasia, Paragraph B Motor Disorganization, and Paragraph C Mental Plus Physical Marked Limitation, Plus the 3 Month Rule That Trips Most Files

The three paragraphs of 11.04 covering vascular insult to the brain, why the 3 month persistence rule decides most files, what aphasia under paragraph A actually requires versus dysarthria, what disorganization of motor function in two extremities means under paragraph B, the marked physical plus marked mental rule under paragraph C, NIH Stroke Scale and neuropsych evidence, plus the residual case at sedentary RFC.

Listing 4.12 in 2026: How Social Security Decides Peripheral Arterial Disease Claims Under the Four Sub-Listings A B C D, Why the ABI 0.50 and Toe Pressure 30 mm Hg Thresholds Decide Most Cases, and What Wins When the Numbers Are Borderline

The four paths under 4.12 covering peripheral arterial disease, why ABI under 0.50 meets paragraph A, the exercise ABI drop of 50 percent with 10 minute recovery under paragraph B, toe systolic pressure under 30 mm Hg under paragraph C, toe-brachial index under 0.40 under paragraph D, non-compressible artery workarounds for diabetes patients, plus grid rule paths at sedentary RFC for claimants 50 and over.

Listing 5.06 in 2026: How Social Security Decides Crohn's Disease and Ulcerative Colitis Claims Under 5.06A and 5.06B, Why the Two Obstructions Rule and the BMI 17.5 Threshold Decide Most Cases, and What Wins When the Listing Falls Short

The 5.06A two-obstructions path requiring stenotic obstruction with proximal dilation on imaging plus two hospitalizations 60 days apart in a 6-month window, the 5.06B six-finding path with hemoglobin under 10 and albumin 3.0 or less, the narcotic medication language workaround, biologic and JAK inhibitor treatment history, and the residual case built on bathroom frequency and absenteeism.

Listing 14.02 in 2026: How Social Security Decides Systemic Lupus Erythematosus Claims Under 14.02A and 14.02B, Why the Two Body Systems Test and the Repeated Manifestations Path Decide Most Cases, and What Wins When the Listing Falls Short

The 14.02A two-organs path with moderate severity in at least one system plus two constitutional symptoms (fatigue, fever, malaise, weight loss), the 14.02B repeated manifestations path with marked functional limitation in ADLs, social functioning, or concentration/persistence/pace, lupus nephritis ISN/RPS classification, belimumab and anifrolumab treatment records, and overlap with APS and Sjogren's.

Listing 13.00 in 2026: How Social Security Decides Cancer Claims Under 13.02 Through 13.30, Why the Three-Year Remission Rule and the Distant Metastases Test Decide Most Cases, and the Treatment Side Effects That Win Without Meeting a Listing

The four basic factors SSA applies to every cancer claim under 13.00B, the distant metastases test that handles most automatic approvals, the three-year remission clock under 13.00H1, the durational windows for head and neck (18 months), bone sarcoma (12 months), acute leukemia (24 months), and bone marrow transplant (12 months), and the residual treatment side effects that win cases that don't meet a listing.

Listing 12.15 in 2026: How Social Security Decides PTSD and Trauma-Related Disorder Claims Under Paragraph A, B, and C, Why the Marginal Adjustment Test Wins When Paragraph B Falls Short, and the Treatment Record That Decides Step 3

The five paragraph A symptom clusters (trauma exposure, re-experiencing, avoidance, mood disturbance, hyperarousal), the four paragraph B mental functioning areas with marked or extreme limit ratings, the two-year paragraph C marginal adjustment path, the medical source statement that wins under 20 CFR 404.1520c, and how VA PTSD ratings translate into Listing 12.15 evidence.

Listing 4.04 in 2026: How Social Security Decides Ischemic Heart Disease Claims Under 4.04A, 4.04B, and 4.04C, Why the 5 METs Threshold and the Three-Episode Rule Decide Most Cases, and the Imaging Findings That Win Without an Exercise Test

The four ischemic findings under 4.04A (ST depression, ST elevation, dropping systolic BP, imaging-confirmed ischemia) at 5 METs or less, the three-episode rule under 4.04B with revascularization or not-amenable-to-revascularization documentation, the 4.04C angiographic stenosis thresholds when exercise testing is too risky, and the very serious ADL limitation requirement that decides most 4.04C cases.

Listing 11.09 in 2026: How Social Security Decides Multiple Sclerosis Disability Claims Under 11.09A and 11.09B, Why the Two Paths Demand Completely Different Evidence, and the Documentation That Wins at Step 3

The McDonald 2024 diagnostic criteria, the extreme motor limitation path under 11.09A (disorganization of motor function in two extremities), the marked physical plus marked mental functioning path under 11.09B, the four mental functioning areas, EDSS scoring and what 6.0+ means at SSA, SDMT and BICAMS for cognitive evidence, FSS and MFIS for fatigue, and the disease modifying therapy record that decides Step 3.

Listing 14.09 in 2026: How Social Security Decides Inflammatory Arthritis Claims Under 14.09A, 14.09B, 14.09C, and 14.09D, Why Ankylosing Spondylitis and Psoriatic Arthritis Have Their Own Subpart, and the Documentation That Decides Step 3

The four subparts of 14.09, the inability-to-ambulate and inability-to-perform-fine-and-gross-movements standards, the organ-system-plus-constitutional-symptoms test under 14.09B, the spine flexion math under 14.09C (45-degree and 30-degree paths), the marked functional limitation test under 14.09D, and the medication and constitutional symptom documentation that wins inflammatory arthritis cases.

Listing 6.06 in 2026: How Social Security Decides Nephrotic Syndrome Disability Claims, Why the 90-Day Lab Rule and Anasarca Both Have to Be Documented, and the Workup Most Files Are Missing

The two proteinuria paths under 6.06A (10 g per 24 hours alone OR 3.5 g per 24 hours with serum albumin 3.0 g/dL or less), the 90-day durability test, why spot protein-to-creatinine ratios at 3.5+ qualify, the strict anasarca definition under 6.00C6, alternative paths via 6.03, 6.04, 6.05, and medical equivalence, plus RFC factors that win at Step 5.

SSR 19-4p in 2026: How Social Security Evaluates Migraine, Cluster, and Tension-Type Headaches, Why Listing 11.02 Is the Anchor, and What Your File Has to Show to Win on Medical Equivalence

The four MDI anchors under SSR 19-4p, why migraine and cluster headache equal 11.02B and 11.02D, the once-a-week and once-every-two-weeks frequency rules, the marked functional limitation test, RFC math on absences and off-task time, and the documentation that wins headache disability cases.

Listing 1.20 in 2026: How Social Security Decides Amputation Disability Claims Under 1.20A, 1.20B, 1.20C, and 1.20D, Why Prosthesis Function Decides Most Cases, and the Documentation That Wins at Step 3

The automatic 1.20A and 1.20B subparts, the functional criteria fights under 1.20C and 1.20D, why Syme amputations are excluded, what counts as a documented medical need for an assistive device, prosthesis use rules under 1.00C6b, and how to get a treating physician statement that fits the listing language.

The SSI Installment Rule in 2026: How Past-Due Payments Over $2,982 Get Split Into Three Six-Month Installments Under Section 1631(a)(10), POMS SI 02101.020, and the Three Ways to Bust the Rule

The $2,982 individual threshold, $4,473 couple threshold, the six month installment cycle, the nine month resource exclusion under POMS SI 01130.600, and the three legal exceptions (terminal illness, outstanding debts for food, clothing, shelter, or medical care, and ineligibility). CA and TX worked examples with attorney fee math.

The SSI Student Earned Income Exclusion in 2026: How a Working Student Under 22 Can Earn Up to $2,410 a Month and $9,730 a Year Without Touching Their SSI Check Under POMS SI 00820.510

The $2,410 monthly and $9,730 annual SEIE caps, the regularly attending student test, the SSA-1372 verification process, how the SEIE stacks with the general income and earned income exclusions, and what happens when a student turns 22 mid year. Real intake math for summer earners and college part timers.

Listing 5.05 in 2026: How SSA Evaluates Chronic Liver Disease, the Seven Paths from Variceal Bleeding to the SSA CLD Score of 20, and the Lab Thresholds That Win at Step 3

The seven paths under 5.05A through 5.05G. The 2-unit transfusion rule for variceal bleeding, the 60-day evaluation rule for ascites and encephalopathy, the ABG altitude tiers for hepatopulmonary syndrome, and the SSA CLD score formula with the sodium correction. CA hepatitis C and TX alcohol-related cirrhosis worked examples.

Listings 2.02, 2.03, and 2.04 in 2026: How SSA Defines Statutory Blindness, the Best-Corrected 20/200 Rule, the 20-Degree Visual Field, and the SGA Bump to $2,830

Statutory blindness under 2.02 and 2.03A versus non-statutory disability under 2.03B, 2.03C, 2.04A, and 2.04B. Better-eye rules, VER testing, MD of 22 dB on HFA 30-2, visual efficiency formula. Blind SGA $2,830 in 2026, no title XVI duration requirement. CA RP and TX diabetic retinopathy worked examples.

Listings 6.03, 6.04, and 6.05 in 2026: How SSA Evaluates Chronic Kidney Disease, the Dialysis Path, the One-Year Transplant Rule, and the Lab Thresholds That Win at Step 3

The dialysis listing 6.03, the automatic one-year transplant grant under 6.04, and the 6.05 lab + complication path with the eGFR 20 cutoff, the 90-day documentation rule, and BMI 18 anorexia criterion. CA and TX worked examples on diabetic nephropathy and PKD.

Listing 11.02 in 2026: How SSA Evaluates Epilepsy, the Once-a-Month and Once-a-Week Seizure Frequency Rules, the 3-Month Observation Window, and the Adherence-to-Treatment Standard That Wins at Step 3

The four paths under 11.02 (A monthly tonic-clonic, B weekly dyscognitive, C and D with marked limitation), the 11.00H4 counting rules, the 3-month adherence floor, and the witness-description requirement. CA idiopathic generalized and TX temporal lobe worked examples.

Listing 3.02 in 2026: How SSA Evaluates COPD and Chronic Lung Disease, the FEV1 and FVC Tables, the DLCO and Arterial Blood Gas Tests, and the SpO2 Cutoffs That Win at Step 3

The four paths under 3.02, full height-based FEV1 and FVC tables, the DLCO 10.5 cutoff, ABG values by altitude, the 87/85/83 percent SpO2 rule, plus CA and TX worked examples on COPD and severe oxygen desaturation.

Listing 4.02 in 2026: How SSA Evaluates Chronic Heart Failure, the 30 Percent Ejection Fraction Rule, the 2.5 cm Wall Plus 4.5 cm Atrium Path, and the 5 METs Exercise Test That Wins at Step 3

The 4.02A1 systolic and 4.02A2 diastolic imaging paths, the B1 contraindicated ETT path, the B2 three-hospitalization rule, the B3 5 METs stress test failure, NYHA crosswalk, plus CA and TX worked examples on HFrEF and HFpEF.

Listing 12.05 in 2026: How SSA Evaluates Intellectual Disorder, the Paragraph A and B Tests, IQ Score Rules Under 12.00H, and Why Adaptive Functioning Matters as Much as the Number

The two paths to a Step 3 win on intellectual disorder, the FSIQ 70 cutoff plus the 71-75 subtest path, accepted IQ tests, the four areas of adaptive functioning, and CA plus TX worked examples.

SSDI Overpayment Waiver in 2026: The Section 204(b) Test, Form SSA-632, the New 10 Percent Recovery Cap, and the $1,000 Streamlined Waiver Path

The two-prong waiver test, the March 2024 O'Malley reforms shifting the burden to SSA, the 10 percent default recovery cap, the $1,000 streamlined waiver, and full SSA-632 walkthrough with CA and TX examples.

Continuing Disability Reviews in 2026: The Medical Improvement Review Standard, MINE/MIP/MIE Diary Categories, and Why Most People Keep Their Benefits

The 8-step adult CDR sequence, the 3-step kids sequence under 416.994a, diary categories, exceptions to medical improvement, and how to win a CDR appeal. CA and TX worked examples.

Form SSA-44 and the IRMAA Life-Changing Event Appeal in 2026: How to Knock Down Your Medicare Premium After Retirement, Divorce, or a One-Time Income Spike

2026 IRMAA brackets up to $9,371/yr per person, the 8 qualifying life-changing events under 20 CFR 418.1205, exactly how to file SSA-44, and worked AZ and GA savings examples.

SSA-1696 and Attorney Fees in 2026: How the $9,200 Fee Agreement Cap Works Under 42 USC 406(a), Section 206(a), and 20 CFR 404.1720

$9,200 fee cap, 25 percent past-due rule, fee agreement vs fee petition, the May 2025 partial rescission, and exactly how Social Security pays your representative. Worked CA and TX examples.

Lump-Sum SSDI Back Pay and the IRC Section 86(e) Election in 2026: How IRS Publication 915 Worksheets Stop a Multi-Year Award From Pushing You Into a Brutal Tax Bracket

Multi-year back pay can shove your taxable benefits to 85 percent in one year. IRC 86(e) lets you refigure as if you got it in the right years. No amended returns. Just line 6c on Form 1040.

Children's SSI in 2026: How 20 CFR 416.924 and 416.926a Use Three Steps and Six Domains of Functioning to Decide Every Kid's Claim

Kid SSI claims don't use the adult 5-step. They use three steps and six domains under 20 CFR 416.926a. Marked vs extreme limitation math, parental deeming, 2026 FBR $1,003, age-18 redetermination cliff, and a worked CA example.

SSI Dedicated Account in 2026: Why Back Pay Over 6 FBR Months Must Go Into a Separate Restricted Account Under POMS SI 02101.020 (And What You Can Actually Spend It On)

If your kid's SSI back pay tops $6,018 in 2026 it can't go in your checking account. POMS SI 02101.020 forces a dedicated restricted account with specific allowed uses, accounting forms, and ABLE transfer rules.

The 5-Step Sequential Evaluation in 2026: How 20 CFR 404.1520 Walks Every SSDI Claim Through Steps 1 Through 5, and Where Most Claims Actually Get Decided

Every SSDI claim runs through the same 5-step decision tree. Step-by-step breakdown of 20 CFR 404.1520 with 2026 SGA numbers, RFC, Grid rules, SSR 24-2p PRW changes, and where claims actually get killed.

The SSI Marriage Penalty in 2026: How Section 1611(e) Cuts Couple Benefits to 1.5x the Individual Rate, Plus Deeming, Holding Out, and the Resource Trap

Two SSI recipients who marry lose roughly 25 percent of their combined benefits. Why the couple FBR is 1.5x not 2x, deeming math, the holding out rule, the $3,000 resource trap, plus California and Texas state-specific dollar examples.

Quick Disability Determination (QDD) in 2026: How POMS DI 23022 and the SSA Predictive Model Pick Fast-Track Cases, and How to Land in That Bucket

SSA's quietest fast-track program closes cases in 20 days instead of 224. You can't apply for it. A predictive model picks you. Here is what the model reads, how QDD differs from CAL, and the seven things you can do on the application to give the model enough signal.

The 5-Day Evidence Rule in 2026: How 20 CFR 404.935 Works at Your ALJ Hearing, and the Three Good Cause Exceptions That Can Save Late Records

Submit or inform 5 business days before your hearing or the ALJ can reject your evidence. Here is the exact rule text, the three mandatory good cause exceptions, how to count the deadline backwards, what the HALLEX manual tells judges to do, and the practical workflow that keeps your record clean.

The Medical Improvement Standard in 2026: How 20 CFR 404.1594 Decides Your CDR, Plus the Group I and Group II Exceptions That Can End Benefits Without Any Improvement

A CDR doesn't ask whether you're disabled today. It asks whether your condition improved since the comparison point decision. Here is how the 8-step CDR sequential under 20 CFR 404.1594 actually runs in 2026, the 5 Group I exceptions, the 4 Group II exceptions, and how to keep your checks coming during appeal.

Employee SGA in 2026: How 20 CFR 404.1574 Handles W-2 Earners, Subsidies, Special Considerations, and Earnings Averaging When You Cross the $1,690 Line

A $2,400 gross paycheck doesn't have to mean cessation. 20 CFR 404.1574 gives you four tools to rebut the SGA presumption: subsidies, special conditions, IRWE, and earnings averaging. Worked dollar examples that turn a $2,400 paycheck into $865 in countable earnings.

Self-Employment SGA in 2026: The Three Tests Under 20 CFR 404.1575, Why Your Net Profit Doesn't Decide Disability, and How to Document Reduced Capacity

Self-employed claimants don't get SGA evaluated by income alone. SSA runs three tests: Significant Services and Substantial Income, Comparability, and Worth of Work. Here is how each test runs in 2026 with the $1,690 SGA threshold, what deductions to take, and how the 24-month rule changes everything for current beneficiaries.

Medical Equivalence Under 20 CFR 404.1526 in 2026: How to Equal a Listing When You Don't Meet One, the SSR 17-2p Evidence Rules, and the Medical Consultant Sign-Off

You can win SSDI at Step 3 even if you don't meet every Blue Book criterion. 20 CFR 404.1526 gives three routes to equal a listing: missing criteria with findings of equal medical significance, impairment not in the Blue Book, and combination of impairments. Here is the 2026 breakdown including SSR 17-2p and the medical consultant sign-off requirement.

Reopening a Prior SSDI or SSI Denial in 2026: The 12-Month Any-Reason Rule, the 4-Year Good Cause Window, and the Anytime Fraud Exception

A closed SSDI or SSI denial isn't always final. 20 CFR 404.987 lets you reopen a prior decision under three different windows: 12 months for any reason, 4 years (SSDI) or 2 years (SSI) for good cause, and anytime for fraud, clerical error, or face-of-record mistakes. Here is the 2026 breakdown with worked examples and the POMS rules SSA actually uses.

Sentence Four vs Sentence Six Remand in 2026: How Federal Courts Send SSDI Cases Back to SSA, the EAJA Fee Difference, and Why It Decides Your Back Pay

When a federal court remands your SSDI case under 42 USC 405(g), it picks either sentence four or sentence six. The choice decides when EAJA fees can be filed, whether you get a final judgment, and how your back pay timeline plays out. Here is the 2026 breakdown of Shalala v. Schaefer, Melkonyan v. Sullivan, the 90-day EAJA window, and the differences that actually matter.

Expedited Reinstatement (EXR) in 2026: How to Restart SSDI or SSI Without Filing a New Claim, the 60-Month Window, and the 6 Months of Provisional Cash

If your SSDI or SSI was terminated because work earnings exceeded SGA, you have 60 months to ask SSA to turn the check back on without filing a new application. Here is the 2026 breakdown of the EXR statute, the medical improvement standard, the 6 months of provisional cash, and worked examples that show how the timeline actually plays out.

Section 207 in 2026: Can Creditors Garnish Your Social Security Disability? The Anti-Attachment Rule, the 4 Federal Exceptions, and the Two-Month Bank Account Shield

Section 207 of the Social Security Act protects your SSDI and SSI from most creditors, but four federal exceptions can still pull money out of your check. Here is the 2026 breakdown of the anti-attachment rule, the child support, federal tax, federal debt, and restitution carve-outs, and the 31 CFR 212 rule that shields two months of benefits in your bank account.

The SSI Resource Limit in 2026: $2,000 and $3,000 Caps, What Counts, What's Excluded, and How to Stay Under the Line

The SSI resource limit is frozen at $2,000 for individuals and $3,000 for couples in 2026, where it has sat since 1989. Here is the 2026 breakdown of what counts as a resource, the home and one-car exclusions, ABLE accounts, burial funds, deeming rules for spouses and parents, and the worked examples that show how SSA decides eligibility.

Section 1619(b) in 2026: How Working SSI Recipients Keep Medicaid After the Cash Check Stops, the State Threshold Table, and the Individualized Threshold Trick

Section 1619(b) lets SSI recipients keep Medicaid even after their cash benefit drops to zero from work earnings. Here is the 2026 state threshold table for all 50 states plus DC, the Medicaid Use Test, the Threshold Test, the 209(b) state quirks, and how to qualify for an individualized higher threshold under POMS SI 02302.050.

Date Last Insured (DLI) in 2026: The 20/40 Rule, How SSA Calculates Your Cutoff, and Why Your Onset Date Decides Everything

Your Date Last Insured is the last day SSA will pay you SSDI benefits, period. Here is the 2026 breakdown of the 20-in-40 quarters rule, how SSA picks your DLI from your earnings record, what happens if your disability started after the cutoff, and worked examples that show how to read your own number.

SSR 96-8p in 2026: How SSA Writes Your RFC, the 7 Strength Demands, and Why Function-by-Function Analysis Decides Your Claim

SSR 96-8p tells SSA how to write your Residual Functional Capacity. It requires function-by-function analysis before exertional categories, a narrative discussion citing specific evidence, and weight given to treating source opinions. Here is the 2026 breakdown of the 7 strength demands, mental categories, and how to spot a defective RFC.

Wounded Warrior and 100% P&T Veterans SSDI in 2026: How Two Different Fast-Track Programs Work, the VA Rating Letter Trick, and Why Both Benefits Stack Without an Offset

Wounded Warriors and 100 percent P&T veterans get fast-tracked SSDI claims in 2026, but the two programs work differently and one trips up almost everyone. Here is the 2026 breakdown of POMS DI 11005.604 and DI 23055, the VA rating letter trick, and why SSDI plus VA disability stack with no offset.

Disabled Widow Benefits in 2026: Section 202(e), the Age 50 Rule, the 7-Year Prescribed Period, and the Remarriage Rules That Trip People Up

Disabled Widow Benefits (DWB) under Section 202(e) pay surviving spouses ages 50 to 59 who can't work. Here is the 2026 breakdown of the prescribed period, the 71.5 percent of PIA payment, the 5-month waiting period, the remarriage rules at ages 50, 55, and 60, and how to file when the deadline is closing in.

SSR 12-2p in 2026: How SSA Evaluates Fibromyalgia, the 1990 vs 2010 ACR Criteria, and the Longitudinal Evidence That Wins These Claims

SSR 12-2p is the only SSA ruling about fibromyalgia. Here is the 2026 breakdown of the 1990 ACR tender point criteria, the 2010 ACR symptom criteria, the 12-month longitudinal record requirement, the exclusion workup SSA expects, and the treating rheumatologist evidence that moves fibromyalgia claims from initial denials to ALJ approvals.

DAC and CDB Benefits in 2026: How Disabled Adult Child Social Security Works, the Onset Before Age 22 Rule, and the Marriage Trap That Ends Most Claims

Disabled Adult Child (DAC) and Childhood Disability Benefits (CDB) pay a disabled adult on a parent's Social Security record. Here is the 2026 walkthrough of the onset-before-22 rule, the 50 percent and 75 percent PIA math, Medicare at month 25, the marriage termination trap under 20 CFR 404.352, and how to keep DAC benefits if you marry another Title II beneficiary.

Listings 1.15 and 1.16 in 2026: How the April 2021 Spinal Disorder Rewrite Changed SSDI Claims for Back Pain, Radiculopathy, and Lumbar Spinal Stenosis

The April 2021 musculoskeletal rewrite replaced old Listing 1.04 with Listings 1.15 (nerve root compromise) and 1.16 (cauda equina and lumbar stenosis), plus 1.18 for major joints. The biggest change is the assistive device requirement under the D criterion. Here is what spinal claimants need to prove in 2026 to meet a Listing, why most back claims now win at step five instead, and how to build the medical record SSA actually wants.

SSR 18-3p and 20 CFR 404.1530 in 2026: How SSA Denies SSDI for Failure to Follow Prescribed Treatment, the Four Prerequisites, and the Good Reason Exceptions That Save Claims

SSR 18-3p replaced the old SSR 82-59 on October 29, 2018 and rewrote how SSA handles failure-to-follow-treatment denials. The agency has to prove four prerequisites before it can deny on this ground, and six good-reason categories let a claimant beat the denial. Here is the 2026 walkthrough of every step, the religious objection rule under 20 CFR 404.1530(c)(2), the cost and side-effect defenses, and how to write the explanation that wins.

AR 24-1(6) Earley in 2026: How the Nationwide Acquiescence Ruling Rewrote Drummond, Killed the Old Adoption Rule, and Changed Every Refiled SSDI Claim

Acquiescence Ruling 24-1(6), effective December 2, 2024, rescinded the old Drummond and Dennard rulings and changed how SSA handles prior ALJ findings in refiled disability claims. Here is what Earley v. Commissioner means in 2026, why the new rule applies nationwide, and how to use prior findings to strengthen your next application.

20 CFR 404.957 in 2026: When ALJs Dismiss SSDI Hearing Requests, the Good Cause Standard for Failure to Appear, and How to Vacate a Dismissal That Killed Your Case

20 CFR 404.957 lets an ALJ dismiss your SSDI hearing request for missed hearings, untimely filings, res judicata, or claimant death. Here is the 2026 breakdown of every dismissal ground, the good cause standard under (b)(2), the 60-day vacate window under 404.960, and how to fight a dismissal that ended your case.

SSR 18-1p in 2026: How SSA Determines Your Established Onset Date, Why It Controls Your Retroactive Benefits, and the AOD vs POD vs EOD Framework That Decides Everything

Your Established Onset Date controls how much retroactive money you get and when Medicare kicks in. Here is how SSR 18-1p and POMS DI 25501.250 set the EOD in 2026, the difference between AOD, POD, and EOD, traumatic vs non-traumatic onset, the Unsuccessful Work Attempt exception, and when ALJs call medical experts to infer onset.

HALLEX I-2-1-60 in 2026: How to Get a Biased ALJ Off Your SSDI Case, the New 2024 Recusal Standards, and Why Appearance of Impropriety Is Now Codified

If your ALJ has a financial conflict, a prior relationship, or has said something that makes a reasonable person question impartiality, you can ask them to recuse. Here is how HALLEX I-2-1-60 works after the August 2024 rewrite by Transmittal I-2-257, the three mandatory disqualification grounds, and the appeal path if the ALJ refuses to step down.

Age 18 SSI Redetermination in 2026: How SSA Re-Evaluates Disabled Children Under the Adult Standard, Why a Third Lose Benefits, and How to Keep Them

When a child on SSI turns 18, SSA must re-evaluate the case under the adult disability standard. About one in three children lose benefits. Here is how the redetermination works, what POMS DI 13006 requires, how Section 301 keeps payments going during vocational training, and the 10 day appeal window that protects benefits.

Federal Court SSDI Appeals in 2026: The 42 U.S.C. 405(g) Civil Action, the 60 Day Clock, the New Supplemental Rules, and Why 60% of Remanded Cases Win

After the Appeals Council denies review, your only option is federal district court. The 60 day clock starts ticking, the new Supplemental Rules govern the filing, and about 60% of cases remanded back to SSA end in approval. Here is the full process, sentence four vs sentence six remands, and how EAJA pays your attorney.

Mental Health Listings 12.04, 12.06, and 12.08 in 2026: How SSA Evaluates Depression, Anxiety, and Personality Disorders at Step 3

The paragraph A medical criteria and paragraph B four functional areas decide every mental health SSDI case at step 3. Here is exactly what marked and extreme mean in the four B areas, how the C criteria save serious and persistent cases, and why 12.08 has no paragraph C.

SSA Compassionate Allowances in 2026: The Full 300-Condition List, the 13 Newest Additions, and How to Get Your SSDI Claim Fast-Tracked

SSA added 13 new conditions on August 11, 2025, bringing the Compassionate Allowances list to 300 total. Approvals run about 10 days versus the 227-day national average. Here is the full updated list, every newcomer, and exactly how to flag your claim correctly.

Medical-Vocational Profiles in 2026: The Three POMS DI 25010.001 Paths That Skip the Grid Rules and Approve You Outright

Three special findings under POMS DI 25010.001 and SSR 24-1p can direct an SSDI allowance before the grid rules ever apply. Here is how the arduous unskilled, no work, and lifetime commitment profiles actually work in 2026.

20 CFR 404.1504 in 2026: Why Your VA Disability Rating No Longer Wins Your SSDI Case (And What Evidence Actually Does)

After the 2017 rule change SSA does not adopt VA disability ratings. Here is what 20 CFR 404.1504 actually requires, how to use the C&P exams and DBQs that move the needle, and what the 100% P&T expedited track looks like.

SSDI Family Maximum Benefit Cap Math 2026: How Auxiliary Benefits Get Reduced When Your Family Hits the Limit

Your SSDI family maximum sets a hard ceiling on what your spouse and children can collect on your record. Here is the 2026 FMB formula, three real worked examples, and the rules that decide whose check shrinks first.

Missing SSDI or SSI Direct Deposit: The 2026 Recovery Playbook

Your payment did not arrive. Here is what to do hour by hour: the 3-business-day rule, the non-receipt claim process, Direct Express card issues, replacement check timelines, and the exact SSA phone trees that work.

SSR 16-3p in 2026: How SSA Evaluates Your Symptoms After Killing the Credibility Standard

SSR 16-3p replaced the old credibility test in 2016 and still controls how SSA judges your pain, fatigue, and mental symptoms in 2026. Here is how the two-step rule works, what the seven 1529(c)(3) factors actually require, and how to argue the rule at every level.

HALLEX I-3-3 in 2026: How the Appeals Council Decides Whether to Remand Your SSDI Case

Most SSDI denials at the hearing level go to the Appeals Council next. HALLEX I-3-3 sets the standards the AC uses to grant review, remand, or deny. Here is how those standards work in 2026, what wins remand, and how Carr v Saul reshaped issue-exhaustion arguments.

20 CFR 404.1520c in 2026: How the Persuasiveness Framework Replaced the Treating Physician Rule and What It Means for Your SSDI Case

For claims filed on or after March 27, 2017, SSA no longer gives controlling weight to your treating doctor. Here is how supportability and consistency under 20 CFR 404.1520c actually work in 2026, with circuit court remand patterns and a field playbook.

SSR 24-2p in 2026: The New 5-Year Past Relevant Work Rule and How It Changes Your SSDI Step 4 Decision

Effective June 22, 2024, SSA shortened the past relevant work window from 15 years to 5 and stopped counting any job that lasted less than 30 days. Here is how SSR 24-2p actually plays out at step 4 and step 5 in 2026, with vocational examples and POMS citations.

Borderline Age Rule in 2026: How to Push SSA to Use a Higher Age Category Under 20 CFR 404.1563 and Win Your SSDI Claim

If you're within six months of turning 50, 55, or 60 and the next grid rule directs a finding of disabled, SSA may move you up. Here's how 20 CFR 404.1563(b), POMS DI 25015.006, and HALLEX I-2-2-42 work after Ard v O'Malley, the six month outer limit, the sliding scale of adverse factors, and two worked examples.

SSR 24-3p in 2026: How the New Vocational Expert Rule Changed SSDI Hearings, Killed SSR 00-4p, and Reshaped Cross-Examination Strategy

SSR 24-3p took effect January 6, 2025 and rescinded SSR 00-4p. The DOT is no longer the controlling source. Here's how VE testimony works in 2026: source identification, methodology explanation, ORS data, obsolete DOT jobs, and the new cross-examination playbook.

DAA Materiality in 2026: How SSR 13-2p Decides Whether Drug or Alcohol Use Sinks Your SSDI Claim

If you have substance use in your medical record, SSA runs a separate six-step analysis on top of the regular five-step sequential evaluation. Here's how SSR 13-2p, 20 CFR 404.1535, and POMS DI 90070.050 actually work in 2026, the irreversible damage carve-out, what counts as a period of abstinence, and worked examples for depression, cirrhosis, and Wernicke-Korsakoff.

D-SNPs in 2026: How Dual Eligible Special Needs Plans Work, What FIDE, HIDE, AIP, and Coordination-Only Mean, and Which One Is Right for SSDI Beneficiaries on Medicaid

If you get SSDI plus Medicaid, you're a dual eligible, and a D-SNP can wrap both programs into one card with $0 premiums, dental, vision, transportation, and a flex card for groceries or utilities. Here's how the four tiers (FIDE, HIDE, AIP, Coordination-Only) compare in 2026, the CY2026 Final Rule changes, integrated ID card rules, and a state-by-state look at Illinois, California, and Tennessee.

Unsuccessful Work Attempt (UWA) Rules in 2026: How a Short Failed Job Doesn't Have to Kill Your SSDI Claim

A short return to work that ended because of your impairment doesn't have to count against you. Here's how SSA's UWA rules under 20 CFR 404.1574(c), SSR 84-25, and POMS DI 24005.001 actually work in 2026, with the 3-month and 6-month thresholds, the 30-day break rule, and worked examples covering single and multiple failed attempts.

Subsidies and Special Conditions in 2026: How SSA-3033 Can Keep You Under SGA Even When Your Paycheck Says Otherwise

Your paycheck might say $2,200 a month but SSA might count only $1,400 of it. Here's how the SSA-3033 employer questionnaire, the subsidy rule under 20 CFR 404.1574(a)(2), and the special conditions rule under POMS DI 10505.010 actually work in 2026, with worked examples and the sheltered workshop presumption.

Closed Period of Disability in 2026: How to Collect SSDI for a Past Disability That Ended Before You Filed

If you were disabled for at least 12 months and went back to work before applying, you may still qualify for a lump-sum SSDI back payment. Here's how POMS DI 25510.001 and 20 CFR 404.1592a work, the 14-month filing deadline, the 5-month waiting period math, and a worked example showing $33,600 on a 21-month closed period.

Dire Need and Critical Case Expedited SSDI Hearings in 2026: How to Move Your Appeal to the Front of the Line

Facing eviction, running out of insulin, or out of food while waiting on an SSDI hearing? HALLEX I-2-1-40 and POMS DI 23020.030 let SSA flag your case as critical and pull it to the front of the docket. Here are the four dire need categories, the documentation each needs, a sample letter, and what happens after the flag is granted.

Blind Work Expenses (BWE) in 2026: The SSI Deduction That Lets Statutorily Blind Recipients Earn Up To $2,285 a Month and Still Keep Most of Their Check

BWE comes off countable earned income after the $65 plus half exclusion under POMS SI 00820.535. That makes it a near dollar-for-dollar boost to your SSI check. Here's the full walkthrough: who qualifies, what counts (taxes, FICA, guide dog, transportation, meals at work), why BWE beats IRWE, and a worked 2026 example for a blind worker earning $27,420 a year.

Medicare Savings Programs in 2026: QMB, SLMB, QI, and QDWI Income Limits, Resource Caps, and What Each One Actually Pays

The four MSPs cover Part B premiums and, for QMB, all Medicare cost sharing. 2026 limits: $1,350, $1,616, $1,816, and $5,405 monthly income, with $9,950 in countable resources. Annual value runs from $6,500 (QDWI) to $17,800 (QMB plus auto-deemed Extra Help). Here's who qualifies, what each tier pays, and how to apply through your state Medicaid office.

IRWE in 2026: The Disability Work Expense Deduction That Keeps SSDI Beneficiaries Under the $1,690 SGA Line

Impairment-Related Work Expenses are the deduction that lets SSDI beneficiaries earn more than $1,690 a month and still pass the SGA test. Here's the 5-part IRWE test under POMS DI 10520, what counts, what SSA rejects, and how to document costs on SSA-820 and SSA-821.

Medicare Extra Help (LIS) in 2026: The $23,475 Income Limit, $18,090 Resource Cap, and What It Saves SSDI Beneficiaries on Part D Drugs

Extra Help cuts Part D drug costs to $5.10 generic and $12.65 brand, and the IRA capped total out-of-pocket at $2,100 for 2026. The income limit is now $23,475 single, $31,725 married. Here's how to qualify with SSA-1020, auto-qualify paths through SSI and MSPs, and the $5,700-a-year value most people leave on the table.

SSDI Spouse Benefits in 2026: The 50 Percent Rule, the Family Maximum, Divorced Spouse Eligibility, and What Your Husband or Wife Can Actually Collect

If you're on SSDI, your spouse may be able to collect on your record. Here's how the 50 percent rule, the 150 percent family maximum, the 10-year divorced spouse rule, and dual entitlement actually play out in 2026, with worked examples and the exact filing path.

Workers Comp Lump Sum Settlements and SSDI Offset in 2026: How Proration Works, the Magic Language That Protects Your Check, and Reverse Offset States

Settle your WC case wrong and SSA can wipe out your SSDI check for years. POMS DI 52150.060 proration, Hartman life-expectancy formula, the 14 reverse offset states, and the settlement language that protects your monthly check.

SSI Age-18 Redetermination in 2026: The Adult Disability Test, the 60-Day Appeal Window, and Why 4 in 10 Cases Get Cut Off

When an SSI child turns 18, SSA runs a fresh adult disability review under 20 CFR 416.987. About 40 percent of cases get cut off. Here's how the adult test works, the 10-day SBC clock, and the SEIE rules that protect part-time earnings.

Disability Hearing Officer (DHO) Hearing Prep in 2026: How the Cessation Reconsideration Hearing Works, What to Bring, and Why It Beats a Paper Review

After you file SSA-789, you can ask for a face-to-face Disability Hearing Officer hearing. It's your best shot at reversing a cessation before the ALJ step. Here's how the DHO hearing runs, what evidence to bring, and how to use the SBC window.

SSA Form HA-501 in 2026: How to Request an ALJ Hearing After Reconsideration, the 60-Day Clock, and What to File With It

After reconsideration is denied, Form HA-501 gets your case in front of an Administrative Law Judge. Here's the 60-day clock, the SSA-3441 and SSA-827 that have to travel with it, the 5-business-day evidence rule, and what to put in Section 5 so the ALJ has a real roadmap.

SSA-789 in 2026: How to Appeal a Disability Cessation Notice, Keep Your Benefits Pending, and Win the Disability Hearing Officer Step

If SSA decided you've medically improved, you have 60 days to appeal with SSA-789 and only 10 days to elect Statutory Benefit Continuation. Here's the SBC election, the Disability Hearing Officer process, what evidence wins, and the overpayment risk people miss.

Continuing Disability Review (CDR) Frequency in 2026: MINE, MIP, MIE Schedules, SSA-454, SSA-455, and the New DCR Handoff

SSA reviews most disability cases every three or seven years, and the new Disability Case Review system that took over in March 2026 changes the workflow. Which diary code you get, what triggers an early review, the SSA-454 vs SSA-455 split, and how to keep benefits when the mail shows up.

Appeals Council Remand Patterns in 2026: How Often It Happens, the Top Reasons, and the Federal Court Backstop That Wins 61% of Cases

The Appeals Council remands about 13% of cases it reviews, and federal court remands 61% of the appeals it touches. Here's what the data actually shows, the top reasons ALJ decisions get sent back, and how to write a remand request that sticks.

SSA-1696 Representative Appointment 2026: $9,200 Fee Cap, Electronic Filing, and What the Form Actually Locks In

The form that puts a rep on your case controls the entire money side of representation. Here's what each section does, the 2026 fee numbers, why electronic filing beats paper, and the seven small mistakes that delay approval.

SSDI Reconsideration Strategy 2026: The 13% Approval Stage Most People Skip Wrong

Reconsideration wins about 1 in 8 cases. Which patterns win, which lose, what to file with the SSA-561, the prototype states reintegration, and the seven mistakes that turn a winnable case into another denial.

SSDI Backlog and Processing Time Update May 2026: Where Initial Claim Decisions Actually Stand

SSA's DDS initial claims backlog dropped from 1.26 million to 831,000. Here's what the current 5-to-8-month wait actually looks like, why the backlog came down, and what speeds up your specific case.

SSA Consultative Exam 2026: What Actually Happens, How To Prepare, and The Mistakes That Sink Claims

A CE letter doesn't mean your claim is denied. Here's what DDS actually wants from the exam, how long it takes by type, what to bring, and the specific mistakes that turn a CE into a credibility problem.

SSA Case Management Modernization 2026: NASC, NWLM, DCR, and What the New Pilot in Nevada and Tennessee Means for Claimants

SSA is replacing decades-old caseload software with NASC, the National Workload Manager, and the DCR Center for medical CDRs. Here's what's live now, what got delayed, and how the April 25 ASC pilot in Nevada and Tennessee changes claim processing.

DAC vs CDB Disabled Adult Child Benefits in 2026: Same Program, Two Names, and the Marriage Penalty Most Families Miss

Disabled Adult Child (DAC) and Childhood Disability Benefits (CDB) are the same SSA program. Here's how the 2026 numbers work, the marriage penalty under Section 1634(c), the 7-year remarriage rule, and what the proposed Fairness Act would change.

Social Security COLA 2027 Projection: 2.8% to 4.0% Range, When SSA Announces, and What It Means for SSDI and SSI Checks

Where the 2027 COLA forecast sits right now (TSCL 2.8%, Mary Johnson 3.2%), why the May 12 BLS update matters, the official mid-October announcement timing, and exactly how each scenario changes SSDI and SSI checks, FBR, SGA, and TWP thresholds.

SSDI ALJ Hearing Prep 2026: Four Standard Hearing Formats, Notice of Ways to Attend, and How to Win at the Hearing Stage

SSA's November 2024 four-format hearing rule, the Notice of Ways to Attend and 30-day objection deadline, the 5-day evidence rule, how to cross-examine the vocational expert, and what to ask your doctor for in a winning Medical Source Statement.

SSI Income Exclusions in 2026: The $20 General Exclusion, $65 Earned Income Rule, and Every Other Way to Keep More of Your Check

Plain-English breakdown of every SSI income exclusion: the $20 general, $65 earned, half-of-earnings rule, ISM (VTR and PMV), student earned income exclusion, PASS plans, IRWE, BWE, and how to handle a lump sum without losing your check.

Protective Filing Date and Retroactive SSDI Benefits in 2026: How One Phone Call Can Lock In an Extra $20,000

How to establish a protective filing date in 5 minutes, how it interacts with the 12-month retroactive cap and 5-month waiting period, the 17-month rule, the windfall offset for concurrent cases, and how rep fees come out of back pay.

Trial Work Period vs Extended Period of Eligibility in 2026: How to Test Work Without Losing SSDI

The 2026 TWP threshold ($1,210), the 9-month rolling window, the 36-month EPE, the 3-month grace period, and Expedited Reinstatement explained without the SSA jargon. Plus a sample timeline and what counts as earnings.

Alleged vs Established Onset Date in 2026: How Your SSDI Onset Date Decides Your Back Pay

Onset date isn't a feeling. It's a strategic call that combines your last day above SGA, the first disabling medical record, your date last insured, and the 17-month retroactive cap. Here's how to pick it right and when to amend.

Vocational Expert Testimony at SSDI Hearings in 2026: How to Cross-Examine, What SSR 24-3p Changed, and the Hypotheticals That Win Cases

The vocational expert is the gate at step five. Here's how SSR 24-3p (effective January 2025) reshaped VE testimony, what Biestek means for cross-examination, and the limits that knock out competitive employment in nearly every hearing.

SSI Redetermination in 2026: How SSA Picks You, What the SSA-8202 Form Asks, and How to Avoid Losing Benefits

Redetermination is the most predictable benefits-loss event in SSI. Here's how SSA picks you, what the long and short forms ask, and the answers that turn a routine review into an overpayment notice.

Section 1619(b) Medicaid Thresholds 2026: All 51 State Caps and How to Keep Medicaid While Working on SSI

Section 1619(b) lets SSI recipients keep Medicaid after their cash payment hits zero. Here's the 2026 threshold for every state, how the individualized cap works, and the traps that knock people off protection.

Reasonable Accommodation vs SSDI in 2026: How to Use the ADA and Apply for Disability Without Sinking Either Case

You can request reasonable accommodations at work and apply for SSDI thanks to Cleveland v. Policy Management Systems. But the language and timing can make or break both cases. Here's how to do both right.

Compassionate Allowances 2026: 300 Conditions, 30-Day Decisions, and How to Trigger the Fast-Track

SSA's Compassionate Allowances program flags 300 severe conditions for expedited approval. Most CAL claims decide in 30 to 60 days. Here's the full 2026 list, what's new, and how to make sure your claim gets flagged.

Medical Source Statement HA-1151 and HA-1152 in 2026: How to Get Your Doctor to Support Your SSDI Claim

A Medical Source Statement is the most powerful piece of evidence in an SSDI file. Here's the difference between HA-1151 and HA-1152, how to ask your doctor, what wins, and what to do if they refuse.

Fibromyalgia Disability SSDI 2026: SSR 12-2p, Tender Points, and What Wins Cases

Fibromyalgia is one of the toughest SSDI cases to win because the SSA can't see it on imaging. SSR 12-2p sets the rules. Here's what the ALJ actually looks for, what wins, and what guarantees a denial.

Lyme Disease Disability SSDI 2026: PTLDS, Listings, and What Wins Chronic Lyme Cases

Chronic Lyme and PTLDS are difficult SSDI cases because there's no listing. The SSA evaluates them as MEDI's at step 5 using residual functional capacity. Here's what wins, what fails, and how the regional case patterns play out.

VA 100% P&T and Wounded Warrior SSDI Fast-Track in 2026: How Veterans Get Priority Processing

Veterans with 100 percent permanent and total VA ratings or Wounded Warrior status get expedited SSDI processing. Here's how each fast-track works in 2026 and how to make sure your claim gets flagged in the system.

SSA-3373 Function Report 2026: How to Fill It Out and Avoid the Mistakes That Kill SSDI Claims

The Adult Function Report decides more SSDI and SSI cases than most applicants realize. A question-by-question walkthrough of how to answer so the form supports your claim instead of sinking it.

SSDI and Long-Term Disability Insurance in 2026: Offsets, Overpayments, and the Math Mistakes Insurers Make

Group LTD policies offset SSDI dollar-for-dollar and demand back pay reimbursement when you're approved. Here's how the offset works, the five math errors showing up in most overpayment letters, and what to do before you sign anything.

Adult Mental Disorder Listings in 2026: How SSA Evaluates Depression, Anxiety, PTSD, Bipolar, Schizophrenia, and Autism

SSA's 12.xx mental disorder listings decide most mental health disability cases. Here's how the eleven adult mental listings work, the four B criteria, when paragraph C applies, and what evidence wins.

DDS Wait Times 2026: How Long Each State Takes to Decide a Disability Claim

Idaho is at 108 days. South Carolina is at 452. The full state-by-state breakdown of DDS initial decision times in 2026, why states differ so much, and what you can actually do to keep your case from sitting.

Pediatric SSI for ADHD in 2026: How to Apply, Listing 112.11, Income Limits, and What Wins Cases

Kids with ADHD can qualify for SSI cash and Medicaid if the condition causes marked or severe limits at school and home. Listing 112.11, the six functional domains, parent income limits, and the school and medical evidence that wins.

PASS in 2026: Plan to Achieve Self Support, How to Set Aside Income, and Keep SSI While Working Toward a Job or Business

A PASS lets you set aside income and resources toward a work goal without losing SSI. How Form SSA-545-BK works, what PASS pays for, the SSDI-to-SSI conversion math, and how it stacks with Ticket to Work, IRWE, and ABLE in 2026.

SSA Login.gov and ID.me in 2026: How to Verify Your Identity, Fix Verification Errors, and Get Into Your my Social Security Account

The old SSA username is gone. Everyone now signs in through Login.gov or ID.me. How each method works, what to do when verification fails, USPS in-person backup, and how to fix the most common errors people hit.

Ticket to Work in 2026: How to Use Your Ticket, Avoid CDRs, and Try Working Without Losing SSDI

SSDI and SSI recipients can use Ticket to Work to try a job with full medical CDR protection. How Employment Networks and State VR work, what Timely Progress requires, and how to stack the Ticket with TWP, EPE, IRWE, and Section 1619(b).

SSI In-Kind Support and Maintenance Rules in 2026: What Counts, What Doesn't, and How to Avoid Reductions

After the September 2024 rule change, food no longer counts as ISM. Shelter still does. How PMV ($351.33 in 2026), the VTR rule, the nationwide rental subsidy exception, and SNAP-based public assistance households now work.

SGA 2026: $1,690 and $2,830 Limits, Trial Work Period Rules, and How Earnings Affect SSDI

The 2026 SGA limit is $1,690 a month for non-blind disability and $2,830 for statutory blindness. How SSA counts gross earnings, the IRWE deduction, the Trial Work Period, and the 36-month Extended Period of Eligibility.

Special Needs Trust vs ABLE Account in 2026: Which One Protects SSI and Medicaid Better

Both protect SSI and Medicaid eligibility, but they differ on age limits, contribution caps, payback rules, and who controls the money. How to choose between an SNT and ABLE, and when to stack both.

Social Security Fairness Act 2026: WEP and GPO Repeal Status, Who Qualifies, and Back Pay Update

SSA paid out $17 billion to 3.1 million people by mid 2025. Here's the current status, who still needs to file, the 6 month vs full retroactive fight, and the new tax problem Congress is trying to fix.

ABLE Accounts and SSI in 2026: New Age 46 Rule, $20,000 Contribution Cap, and How to Save Without Losing Benefits

The ABLE Age Adjustment Act took effect January 1, 2026. Onset before age 46 now qualifies. $20,000 annual cap, $100,000 SSI exclusion, ABLE-to-Work extras, 529 rollovers, and the new Saver's Credit on contributions.

SSI and Social Security May 2026 Payment Schedule: Why Some Checks Arrive Earlier and Others Later

SSI lands May 1. SSDI splits between May 13, 20, and 27 by birthday. Pre 1997 recipients get paid May 1 because May 3 is a Sunday. Full schedule, the dual payment rule, and what to do if your deposit is late.

Concurrent SSDI and SSI Benefits: When You Can Collect Both in 2026

About 2.5 million people collect both. The 2026 rules, the $20 income exclusion, the resource and income tests, three worked examples (Maria, David, Janet), state supplements, and what happens when COLA pushes your SSDI above the threshold.

Auxiliary Benefits for Dependent Children of SSDI Recipients: 2026 Rules, Amounts, and How to Apply

When you get SSDI, your kids may also be owed money. This guide covers the 50 percent rule, the family maximum cap, the 18 to 19 school exception, the SSA-4 application, and what to do when your family hits the FMAX with worked examples and the back of envelope math.

The SSDI Extended Period of Eligibility (EPE): How the 36 Month Safety Net Works in 2026

After the Trial Work Period ends, the EPE gives you 36 months to swing in and out of work without reapplying. This guide covers cessation, the 3 month grace period, IRWE deductions, what happens after the 36 months, Expedited Reinstatement, and the mistakes that cost benefits.

The IRS Lump Sum Election for SSDI Back Pay: How to Cut Your Tax Bill in 2026

The Publication 915 lump sum election spreads SSDI back pay across the years it actually covers, often dropping the taxable portion to nearly zero. Eligibility, the worksheet math, two worked examples, and how to enter LSE on Line 6b without amending old returns.

Representative Payee Duties and Annual Reporting Rules: A Plain English 2026 Guide

If you manage benefits for someone else, you have legal duties most people get wrong. This guide covers the four duty buckets, the SSA-623, 6230, and 6233 forms, the 10-day reporting rule, dedicated SSI accounts, and the criminal exposure under 42 U.S.C. 408 if you misuse funds.

The Pickle Amendment: How to Keep Medicaid After You Lose SSI in 2026

Lost SSI because of a Social Security cost of living increase? You may still qualify for Medicaid under the Pickle Amendment, and most caseworkers miss it. Includes the four-condition test, the 2026 reduction factor table, worked examples, and step-by-step screening.

Long COVID Disability Benefits in 2026: How to Build a Claim That Wins

Long COVID claims still get denied at high rates because of how SSA evaluates them. This guide covers SSR 14-1p, the listings that actually work, specialist documentation by symptom, the objective tests that move reviewers, and a winning RFC strategy.

How to Request Expedited SSDI Processing: TERI, Dire Need, Military, and Compassionate Allowances (2026)

Five fast-track categories can move your SSDI claim to the front of the line. This guide covers TERI, Compassionate Allowances, military casualty, wounded warrior, and dire need requests with sample letters and exact POMS and HALLEX citations.

Section 301: Keep SSDI or SSI While in Vocational Rehab Even After a Not-Disabled Finding (2026)

Section 301 lets you keep receiving SSDI or SSI payments during a vocational rehab program even when SSA decides you are no longer disabled. Covers approved programs, the written request process, Age 18 Redetermination, and a sample response letter.

SSDI and Unemployment Benefits: Can You Get Both in 2026?

You can technically collect SSDI and unemployment at the same time, but most people who try end up losing one or both. This guide walks through the 2012 Cristaudo memo, the seven offset states, the inconsistency trap, and three real scenarios.

How to Report Income Changes on SSDI: Wages, Self-Employment, and What Happens If You Don't (2026)

Every SSDI and SSI beneficiary has to tell SSA about wages. This guide covers the my Social Security wage reporter, Form SSA-821, SSI monthly rules, self-employment reporting, Trial Work Period tracking, and how to fight an overpayment notice.

Disabled Adult Child (DAC) Benefits: How Parents' Social Security Pays a Disabled Adult Forever (2026)

DAC pays an adult disabled before age 22 on a parent's Social Security record: 50% of a living parent's PIA, 75% of a deceased parent's PIA. Covers the pre-22 rule, marriage trap, age-18 redetermination, Medicare wait, and the Section 1634(c) Medicaid protection.

Disability Onset Date Strategy: AOD vs EOD and Why It Decides Your Back Pay (2026)

Your Alleged Onset Date versus Established Onset Date can make a five-figure difference in back pay. Here's how SSR 18-1p works, the earnings floor, the medical floor, the DLI trap for SSDI, and a worked example showing a $14,000 swing.

Disabled Widow and Widower Benefits (DWB): How to Qualify in 2026

DWB pays between ages 50 and 60 on a deceased spouse's record. Current spouses need 9 months of marriage; divorced spouses need 10 years. The 7-year prescribed period controls when your disability must have started. Here's how to qualify, how much it pays, and the remarriage rule that catches people off guard.

How to Read Your SSDI Award Letter: Every Section Explained for 2026

Just got your Notice of Award? This line by line breakdown covers your established onset date, five-month waiting period, back pay math, monthly PIA, payment schedule (by birthday), Medicare waiting period, CDR frequency, and every offset that might shrink your check.

SSDI Denied for Insufficient Work Credits: What to Do in 2026

About 40% of SSDI denials are technical, not medical. If you got denied for insufficient work credits, you can't appeal the rule, but SSI, DAC, DWB, or a corrected earnings record often open other paths. Here's exactly what to do this week.

Blindness and Low Vision Disability Benefits: Qualifying for SSDI and SSI in 2026

8.29 million Americans live with a vision disability. Statutory blindness has a higher SGA limit ($2,830 vs $1,690 in 2026), and listings 2.02, 2.03, and 2.04 each use different evidence. Here's how to qualify, what tests SSA requires, and the mistakes that sink most vision claims.

What to Do When Your Disability Benefits Are Cut Off: 2026 Appeal Guide

SSA cessation notices follow strict timelines. The 10-day rule (Form SSA-795) keeps your checks coming during appeal. Here's how cessation works, the real reasons benefits stop, and step by step what to do when you open that envelope.

SSDI and Workers Compensation Offset: How the 80% Rule Works in 2026

Combined workers comp and SSDI can't exceed 80% of your pre-injury earnings (ACE). 15 reverse offset states flip the rule. Florida, New Jersey, and Washington end reverse offset at age 62. Here's how the math works and how to protect your lump-sum settlement.

Rheumatoid Arthritis Disability Benefits: How to Qualify for SSDI and SSI in 2026

About 10.6 million US adults have RA, and it's listed under Blue Book Listing 14.09. Here's how to qualify through the listing or the RFC pathway, what medical evidence SSA needs, and why most RA claims actually get approved through a different route than you'd expect.

Disability Reconsideration: What to Expect, How to Win, and What Comes Next in 2026

Denied at the initial level? Reconsideration is your first appeal, and the approval rate is only 13-16%. Here's the 60-day deadline, required forms (SSA-561, SSA-3441, SSA-827), skip states, and how to build a case that actually wins.

SSI Back Pay: How It Works, Installment Rules, and How to Protect Your Benefits in 2026

SSI back pay doesn't come as a lump sum. It gets split into installments, and if you don't manage it right, you can lose your monthly benefits. Here's the 3-installment rule, the 9-month exclusion window, ABLE accounts, and smart spend-down strategies for 2026.

Social Security Benefit Cap 2026: What the $50,000 Limit Proposal Means for Disability Recipients

A new proposal would cap Social Security benefits at $50,000/year for individuals and $100,000 for couples. Most SSDI recipients won't hit that ceiling, but the trust fund insolvency driving this proposal affects everyone. Here's what you need to know.

Is Social Security Running Out of Money? What the 2032 Insolvency Date Means for SSDI and SSI

The CBO just moved the trust fund insolvency date to 2032, with a projected 28% automatic benefit cut. But the disability trust fund is separate and solvent through 2098. Here's why that distinction matters and what risks still exist for SSDI recipients.

COPD Disability Benefits: How to Qualify for SSDI and SSI in 2026

COPD is the 5th leading cause of death in the US, killing over 141,000 people a year. If your lung function is bad enough to keep you from working, you may qualify under Blue Book Listing 3.02. Here's how spirometry values, hospitalizations, and RFC evaluations factor into your claim.

Kidney Failure and Dialysis Disability Benefits: SSDI and SSI Guide for 2026

Over 808,000 Americans live with end-stage kidney disease, and 68% are on dialysis. If you're on chronic dialysis or had a kidney transplant, you can qualify automatically under Blue Book Listings 6.03 and 6.04. Plus, ESRD gets you immediate Medicare with no 24-month wait.

SSDI and Medicare in 2026: The 24-Month Waiting Period Explained

Most SSDI recipients wait 29 months from disability onset before Medicare kicks in. That's a 5-month SSDI wait plus a 24-month Medicare wait. Here's exactly how the timeline works, who gets exceptions, and how to cover the gap with Medicaid, COBRA, or marketplace plans.

My Social Security Account Changes in 2026: What You Need to Know About Login.gov and ID.me

SSA killed the old username and password system. As of June 2025, you need Login.gov or ID.me to access your my Social Security account. Here's how to switch, what you can do online, and why disability applicants should set this up now.

Autism Spectrum Disorder Disability Benefits: SSDI and SSI in 2026

The CDC says 1 in 31 kids have autism, and those kids grow up. Adults with ASD can qualify for SSDI, SSI, or Disabled Adult Child benefits. Here's how SSA evaluates autism under Listing 12.10, what evidence you need, and how the process works.

How to Get a Disability Lawyer in 2026: Finding the Right Attorney for Your SSDI or SSI Claim

Claimants with attorneys win at nearly double the rate of those without. Here's where to find disability lawyers, how to evaluate them, what fees look like, and when representation makes the biggest difference for your case.

Chronic Fatigue Syndrome Disability Benefits: How to Get Approved for SSDI or SSI in 2026

CFS isn't in the SSA's Blue Book, but you can still qualify. The SSA evaluates chronic fatigue syndrome under Social Security Ruling 14-1p. Here's what medical evidence you need, how the RFC assessment works, and why most successful CFS claims are won at the ALJ hearing level.

12 Disability Application Mistakes That Get Claims Denied in 2026

About 64% of initial SSDI applications get denied. Many of those denials are preventable. From insufficient medical evidence to missing the 60-day appeal deadline, here are the 12 most common mistakes and exactly what to do instead.

What Happens at a Disability Hearing in 2026: The Full Process Explained

The ALJ hearing is where most people actually win their benefits. The national average hearing approval rate is about 50%, and some offices hit over 70%. Here's what to expect before, during, and after your hearing, including what the judge asks and how the vocational expert can make or break your case.

How to Write a Disability Appeal Letter That Actually Gets Results

You have 60 days from the date of your denial to file an appeal, and the letter you write matters more than most people think. Only about 13% of reconsideration appeals succeed, but the ones that win share common traits. Here's the exact format, what to include, and a template you can follow.

Epilepsy Disability Benefits in 2026: How to Qualify for SSDI and SSI

About 2.9 million adults in the US have active epilepsy, and it's one of the conditions SSA evaluates under Blue Book Listing 11.02. Approval depends on seizure type, frequency, and how well medication controls them. Here's what SSA looks for and how to build a strong case.

SSDI Overpayment in 2026: What to Do When SSA Says You Owe Money

SSA changed the overpayment recovery rate to 100% of your monthly check starting March 2025, up from the old 10% default. If you got an overpayment notice, you have options: request a waiver, appeal the amount, or set up a payment plan. Here are the deadlines, forms, and steps.

SSI Income Limits and Countable Income in 2026: How Much You Can Earn

The 2026 SSI federal benefit rate is $994 per month for individuals. But the income rules are complicated. Here's how SSA counts earned and unearned income, the exclusions that protect your check, and the programs that let you save and work without losing benefits.

Disability Consultative Exam: What to Expect and How to Prepare

SSA orders a consultative exam for about 40% of disability claims. The exam is free, lasts 15-60 minutes, and the results can make or break your case. Here's exactly what happens, who pays, and 10 ways to prepare.

Bipolar Disorder Disability Benefits in 2026: How to Qualify for SSDI and SSI

Bipolar disorder affects 5.7 million Americans, and it's one of the top conditions approved for disability. SSA evaluates it under Blue Book Listing 12.04 with specific criteria. Here's what the approval process looks like and how to build a strong case.

SSDI Back Pay and Taxes in 2026: How Much You Owe and How to Pay Less

SSDI back pay is taxable, but most people don't owe anything. If you do, the lump-sum election method from IRS Publication 915 can cut your bill. Three real scenarios with actual dollar amounts show how it works.

Military Disability vs SSDI in 2026: Can Veterans Get Both?

Yes, you can collect VA disability and SSDI at the same time. VA benefits are tax-free and don't reduce your SSDI payment. A 70%+ VA rating can help your SSDI claim. Here is how both programs work together.

SSA Hiring Freeze and Staffing Crisis 2026: What It Means for Your Disability Claim

The SSA cut 7,000 jobs and froze hiring. Processing times are climbing. Here is what the staffing crisis means for your disability application and what you can do to protect your claim right now.

Disability Attorney Fees and Costs in 2026: What You Actually Pay and How the Fee Cap Works

Disability attorneys charge 25% of back pay up to $9,200. No upfront cost, no hourly rate, and no fee if you lose. Here is how fee agreements work, what incidental costs to expect, and when the cap does not apply.

How to Fill Out the SSA-3373 Function Report Without Hurting Your Disability Claim

The SSA-3373 is one of the most important forms in your disability case. Most people fill it out wrong. This guide walks through every section with real examples of answers that help and answers that hurt your claim.

Fibromyalgia and Social Security Disability in 2026: How to Get Approved When There Is No Blue Book Listing

Fibromyalgia is not in the SSA Blue Book but has a 58% approval rate. SSR 12-2p sets the rules. Here is exactly how to prove your claim with RFC evidence, medical records, and the right documentation strategy.

SSA Field Office Closures in 2026: Which Offices Are Closing and What It Means for Your Disability Claim

26 SSA field offices closed in 2025, 7,000+ employees gone, and the agency wants to cut in-person visits by half. Here is the full closure list, how it impacts SSDI and SSI claims, and what you should do right now.

Federal Court Disability Appeals: Taking Your Case Beyond SSA in 2026

If the Appeals Council denied your case, federal district court is the next step. You have 60 days to file. Here is how it works, what it costs, typical outcomes, and whether it is worth pursuing your disability claim in court.

Social Security Disability for ALS (Lou Gehrig's Disease): Compassionate Allowances Fast Track in 2026

ALS is on the Compassionate Allowances list and is the only condition with no five-month SSDI waiting period. Blue Book Listing 11.10. Here is how to get benefits quickly, the medical evidence you need, and VA benefits for veterans.

Social Security Disability for Multiple Myeloma: Blue Book 13.07 and How to Qualify in 2026

Multiple myeloma has a dedicated Blue Book listing under Section 13.07. If your cancer is progressing despite treatment or you had a stem cell transplant, you may qualify automatically. Here is how the listing works, the RFC pathway, and what medical evidence you need.

SSDI Back Pay Timeline: How Long It Takes and What to Expect in 2026

SSDI back pay usually arrives within 60 days of approval as a lump sum. SSI back pay may come in three installments. Here is the complete timeline, how to calculate your back pay, retroactive benefits, attorney fees, and tax implications.

How SSA Investigates Disability Claims: The 5-Step Process Explained for 2026

What actually happens after you file for disability? DDS examiners, medical consultants, the 5-step sequential evaluation, consultative exams, RFC assessments, and the Grid Rules. Here is the full behind-the-scenes breakdown.

Social Security Disability for Scoliosis: How to Get Approved Without a Blue Book Listing

Scoliosis has no dedicated Blue Book listing, but that does not mean you can't get SSDI. Here's how to qualify through spine disorder listings, the RFC pathway, and why your Cobb angle and combined conditions matter more than the diagnosis alone.

Social Security Disability for Schizophrenia: 80% Approval Rate and How to Qualify

Schizophrenia has one of the highest SSDI approval rates of any condition at roughly 80%. Here's how Blue Book listing 12.03 works, the two pathways to qualify, and what evidence you actually need to get approved.

How to Fill Out the SSA-3368 Disability Report: Section-by-Section Guide

The SSA-3368 is the 14-page form that can make or break your disability claim. This section-by-section walkthrough covers every part of the form, the mistakes that lead to denials, and how to describe your limitations so SSA actually pays attention.

Social Security Disability for Sleep Apnea: How to Get Approved

Sleep apnea affects 25 million Americans but SSA won't approve it easily. Here's exactly how to build a winning claim, which Blue Book listings apply, and why the CPAP compliance trap catches so many people off guard.

What Happens to SSDI When You Reach Retirement Age in 2026?

Your SSDI does not stop at 65. It converts to retirement benefits at your full retirement age, which is 66 or 67 depending on when you were born. Here's everything that changes and what stays exactly the same.

Social Security Disability for Traumatic Brain Injury (TBI): How to Get Approved

TBI can qualify for SSDI under Blue Book 11.18, but the 3-month persistence rule trips up a lot of claims. Here's how both approval pathways work and what documentation actually wins these cases.

VA Disability and SSDI: Can You Get Both in 2026?

Yes, you can get VA disability and SSDI at the same time. Learn exactly how both programs work together, what the rules are, and how to get the most out of both benefits.

Social Security Disability for Peripheral Neuropathy: How to Get Approved

Peripheral neuropathy can qualify you for SSDI or SSI if it limits your ability to work. Here's what SSA looks for, how the Blue Book listing works, and how to build a strong claim.

Does an Inheritance Affect SSDI or SSI Benefits in 2026?

Inheriting money or property hits different depending on which disability program you're on. SSDI recipients have nothing to worry about. SSI recipients need to act fast. Here's what to do.

Social Security Disability for Parkinson's Disease: How to Get Approved in 2026

A Parkinson's diagnosis alone isn't enough. Learn Blue Book 11.06 pathways, the 3-month treatment rule, how "on/off" levodopa cycles affect your claim, and why the Grid Rules help claimants 50 and older get approved.

Social Security Disability for Hearing Loss: What You Need to Qualify in 2026

Only profound hearing loss qualifies under Blue Book 2.10: 90 dB air conduction threshold or a word recognition score of 40% or less. Learn the strict testing rules, the cochlear implant pathway, and the RFC approach if you don't meet the thresholds.

SSDI and Divorce: How Getting Divorced Affects Your Disability Benefits in 2026

Your own SSDI benefits are not affected by divorce. But SSI is different. Learn how spousal deeming ends at divorce (often increasing SSI), whether your ex can collect off your record, and what happens to children's benefits.

Social Security Disability for Crohn's Disease: How to Get Approved in 2026

Only 26% of Crohn's claims get approved initially, but 76% win at hearings. Learn Blue Book Listing 5.06 pathways, the RFC bathroom access argument, and what medical records actually move the needle.

Social Security Disability After a Stroke: What You Can Claim and How to Qualify in 2026

795,000 Americans have a stroke each year. Learn the 90-day waiting rule, Blue Book 11.04 pathways (aphasia, motor function, combined physical and mental), and the Grid Rules that help claimants 50 and older.

Working Part-Time on SSDI in 2026: Rules, Limits, and How to Keep Your Benefits

The 2026 SGA limit is $1,690/month. Learn how part-time work affects SSDI vs SSI, what IRWEs can reduce your countable earnings, and why even $25/hour part-time can put your claim at risk.

Social Security Disability for Kidney Disease: CKD, Dialysis, and How to Qualify in 2026

37 million Americans have chronic kidney disease and most don't know it. Learn the Blue Book Section 6.00 listings for dialysis, transplant, nephrotic syndrome, and how CKD stages affect your SSDI claim.

SSDI Trial Work Period Explained: How to Test Working Without Losing Benefits in 2026

The Trial Work Period lets you work for 9 months and keep your full SSDI check. The 2026 threshold is $1,210 per month. Learn exactly how TWP, EPE, and Expedited Reinstatement work.

Social Security Disability for Lupus: How to Get Approved in 2026

About 1.5 million Americans have lupus, and 90% are women. Learn the Blue Book 14.02 criteria, ACR diagnostic standards, how flares affect your RFC, and what evidence gets lupus claims approved.

Social Security Disability for COPD: How to Qualify and Get Benefits in 2026

About 11.7 million Americans have COPD and it's the 5th leading cause of death in the US. Learn the Blue Book 3.02 criteria, the 4 GOLD stages, and how spirometry results determine if you qualify.

SSI Resource Limits in 2026: How Much Can You Have in the Bank?

The SSI resource limit is $2,000 for individuals and hasn't changed since 1989. Find out what counts, what's excluded, and how ABLE accounts let you save more without losing benefits.

Why Disability Claims Get Denied: The 10 Most Common Reasons in 2026

62% of initial disability applications are denied. These are the 10 most common reasons SSA says no, and exactly how to fix each one before you apply or appeal.

Social Security Disability for Epilepsy: How to Qualify and Get Approved in 2026

About 3.4 million Americans have epilepsy. If your seizures meet Blue Book 11.02 criteria despite treatment, you can qualify for SSDI. Learn the frequency thresholds, evidence you need, and the RFC pathway.

SSDI Overpayment: What to Do When Social Security Says You Owe Money

SSA has $23 billion in uncollected overpayments and now recovers 100% of your benefits. You have 3 options: appeal, request a waiver, or set up a payment plan. Know the deadlines.

What to Expect at a Disability Hearing: A Step-by-Step Walkthrough for 2026

The ALJ hearing is your best shot at getting approved, with a 58.3% approval rate. Find out who will be in the room, what the judge will ask, and how to prepare.

Social Security Disability for Multiple Sclerosis: Your Guide to Getting Approved in 2026

MS has the highest SSDI approval rate of any condition at 68%. Learn about Blue Book Section 11.09, the RFC pathway, and how to build a strong case with your neurologist.

SSDI and Medicare: When Your Coverage Starts and What to Do While You Wait

There is a 24-month waiting period before Medicare kicks in after SSDI approval. Find out your options during the gap, including Medicaid, marketplace plans, and COBRA.

Residual Functional Capacity (RFC): The Key to Winning Your Disability Case in 2026

Over 70% of disability approvals come through the RFC assessment, not the Blue Book. Learn the 5 exertional levels, the grid rules, and how to get your doctor to fill out an RFC form.

Social Security Disability for Cancer: How to Get Approved in 2026

Cancer has a 64% SSDI approval rate. Learn which cancers qualify under Blue Book 13.00, how Compassionate Allowances speed up approval, and what to do if treatment side effects keep you from working.

Continuing Disability Review (CDR): How to Keep Your Benefits in 2026

A CDR can put your disability benefits at risk. Find out how SSA decides when to review your case, what forms you need, and how to avoid losing your SSDI or SSI payments.

How Much Does a Disability Lawyer Cost? The Real Numbers for 2026

Disability lawyers work on contingency, so you pay nothing upfront. The fee is capped at 25% of back pay or $9,200, whichever is less. Here is exactly what you will owe in different scenarios.

Long Term Disability vs. Social Security Disability: What You Actually Need to Know

LTD insurance and SSDI are two very different programs, but most LTD policies require you to apply for SSDI. Learn how offsets work, which pays more, and when you can collect both.

Disability Benefits After Age 62: Why SSDI Almost Always Beats Early Retirement

If you're 62 and disabled, SSDI pays your full retirement benefit while early retirement cuts it by up to 30%. That's $450/mo you'd lose forever. Here's the math and what to do.

Compassionate Allowances: The Fast Track to Disability Benefits (300 Conditions That Qualify)

Standard SSDI takes 7+ months. But 300 conditions on the Compassionate Allowances list can get approved in as little as 10-14 days. Here's the full list, how it works, and how to apply.

Disability Benefits for Diabetes: What Qualifies and How to Get Approved

Diabetes alone won't qualify you for SSDI, but complications like neuropathy, kidney disease, and vision loss can. Learn which Blue Book listings apply and how the RFC pathway works.

Social Security Disability for Migraines: Can You Get Approved?

There's no Blue Book listing for migraines, but you can still get approved through SSR 19-4p medical equivalence or an RFC assessment. Here are the three paths to benefits.

Social Security Disability Work Credits Chart: How Many You Need in 2026

Before SSA looks at your medical condition, they check your work credits. In 2026, you earn 1 credit per $1,890. Here's the full chart by age plus the 20/40 rule explained.

Disability Benefits for Back Problems: How to Get Approved in 2026

Back problems are one of the top reasons people file for SSDI. Here's how the SSA evaluates spine conditions under Blue Book listings 1.15, 1.16, and 1.17, plus what RFC means for your claim.

Social Security Disability Medical Records: What the SSA Actually Needs

Medical records are the single most important part of your disability claim. Learn exactly what the SSA considers acceptable evidence, how RFC reports work, and how to avoid gaps that kill claims.

Social Security Disability Denials by State: Where You Live Matters

Initial approval rates range from 34.8% in Arizona to 57.4% in New Hampshire. See how your state compares at every stage of the disability process, from initial application to ALJ hearing.

The 2026 SSDI COLA Increase: How Much More You'll Get and What Changed

The 2026 COLA is 2.8%. Average SSDI payments went from $1,586 to $1,630 per month. Here's what changed for SSDI, SSI, SGA limits, and Medicare premiums.

Social Security Disability for Heart Conditions: Which Ones Qualify in 2026

The SSA Blue Book lists 8 heart conditions that can qualify for disability. CHF, ischemic heart disease, arrhythmias, and more. Here's what you need to know.

Social Security Disability for Arthritis: How to Qualify in 2026

Arthritis is one of the most approved disability conditions. Learn which types qualify under Blue Book Listings 1.00 and 14.09, and what evidence you need.

How to Calculate Your Social Security Disability Back Pay in 2026

Learn how SSDI back pay is calculated step by step, including the 5-month waiting period, retroactive benefits cap, and real examples using 2026 payment amounts.

Social Security Disability at Age 50: How the Grid Rules Work in Your Favor

After age 50, the SSA's grid rules make it easier to qualify for disability benefits. Learn how age, education, and work history affect your approval odds.

The Social Security Disability Consultative Exam: What It Is and How to Prepare

Got a letter about a consultative exam? Here's what happens during the appointment, what to bring, common mistakes to avoid, and how it affects your claim.

How to Get Approved for Social Security Disability Fast in 2026

Compassionate Allowances, TERI cases, QDD, and practical tips that can cut your disability wait time from years to weeks.

Social Security Disability for Veterans: Can You Get Both VA and SSDI in 2026?

Yes, you can get VA disability and SSDI at the same time. VA benefits are tax-free and don't reduce your SSDI. Here's exactly how it works.

Social Security Disability Judge Approval Rates (2025 Data by Hearing Office)

The national average ALJ approval rate is 58-59%. But some offices approve 84% while others approve just 41%. Here's the full data by hearing office.

How Much Social Security Disability Will I Get in 2026? (The Real Numbers)

The average SSDI payment is $1,630 per month in 2026. The max is $4,152. Here's how to figure out what you'd actually get based on your work history.

Social Security Disability Income Limits for 2026 (What You Can Earn and Keep)

The SGA limit for 2026 is $1,690 per month. Here's how income limits work for SSDI and SSI, what counts as earnings, and how to keep your benefits.

The SSDI 5-Month Waiting Period Explained (And How to Deal With It)

There's a mandatory 5-month wait before your first SSDI check. Here's how it works, the exceptions, and what you can do to survive financially.

Is Social Security Disability Taxable? Here's What You Actually Owe

SSDI can be taxable if your combined income is high enough. SSI is never taxable. Here's the IRS formula, the exact thresholds, and how to figure out what you owe.

Getting Social Security Disability for Fibromyalgia in 2026

Fibromyalgia is not in the Blue Book, but you can still get approved. SSR 12-2p changed the game. Here's how the SSA evaluates fibro claims and what evidence you need.

Social Security Disability for PTSD: How to Qualify in 2026

PTSD falls under Blue Book Listing 12.15. Here's exactly what the SSA requires, how to prove your functional limitations, and what to expect at the hearing.

Can You Get Social Security Disability for Chronic Pain?

Chronic pain alone won't qualify you, but the underlying condition causing it might. Here's how the SSA evaluates pain claims and what medical evidence you need.

Social Security Disability for Bipolar Disorder: What You Need to Know

Bipolar disorder qualifies under Listing 12.04. Here's what the SSA looks for, how to prove your manic and depressive episodes are disabling, and why treatment records matter.

How Long Does It Take to Get Social Security Disability in 2026

From 7 months for an initial decision to 3+ years if you go all the way to a hearing. Here's the real timeline at every stage and how to speed things up.

Social Security Disability for Anxiety and Depression in 2026

Yes, you can get disability for mental health. Here's what SSA looks for under Listings 12.04 and 12.06, what evidence you need, and why most claims get denied.

10 Mistakes That Get Your Social Security Disability Claim Denied

65% of initial claims get denied. These are the 10 most common reasons why, and how to avoid every single one of them.

How to Win Your Social Security Disability Hearing in 2026

54% of people win at their ALJ hearing, and having a lawyer triples your odds. Here's how to prepare, what to expect, and how to give yourself the best shot.

SSDI vs SSI - What's the Difference and Which One Should You Apply For

SSDI averages $1,493/month, SSI maxes out at $994. One needs work credits, the other doesn't. Here's a plain breakdown of both programs and how to pick the right one.

Can You Work While on Social Security Disability in 2026?

The SGA limit is $1,690/month in 2026, but there's a 9-month trial work period and other programs that let you test the waters without losing benefits.

Social Security Disability Changes in 2026 - What You Need to Know

The 2.8% COLA, new SGA limits, SSI payment increases, and what the SSA staffing changes mean for your claim in 2026.

How Long Does It Take to Get Social Security Disability Back Pay

What back pay is, how it gets calculated, how long you will wait for it, and what to do if your payment is taking too long.

What Conditions Qualify for Social Security Disability in 2026

The Blue Book, the top 10 most approved conditions, Compassionate Allowances, and how SSA actually decides who qualifies.